{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/am8b03111.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": "error", "content": "<p>Designable coordination polymers\nwith suitable chemical diversities and biocompatible structures have\nbeen proposed as a promising class of vehicles for drug delivery systems.\nHere, we hydrothermally synthesized a novel one-dimensional (1D) coordination\npolymer, [Zn\u00ad(H<sub>2</sub>O)<sub>6</sub>K<sub>2</sub>(H<sub>2</sub>BTC)<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>]\u00ad(H<sub>2</sub>BTC)<sub>2</sub>\u00b72H<sub>2</sub>O, where H<sub>3</sub>BTC = benzene-1,3,5-tricarboxylic\nacid (trimesic acid), <bold>cp.1</bold>. As the hydrogen bonds stabilized\n1D chains in three dimensions, the <bold>cp.1</bold> could be a good\ncandidate for delivering small-molecule chemotherapeutics such as\n5-fluorouracil (5-Fu). The synthesized <bold>cp.1</bold> showed a\nremarkable 5-Fu loading of 66% with encapsulation efficiency of 98%\nand almost complete release process. The 5-Fu-loaded <bold>cp.1</bold> displayed a time-dependent cytotoxicity effect against breast cancer\ncell lines MCF-7 and 4T1. The cellular uptake of <bold>cp.1</bold> particles was investigated via confocal laser scanning microscopy\nusing fluorescein isothiocyanate and LysoTracker Red staining. Furthermore,\nthe in vivo antitumor impact of 5-Fu-loaded <bold>cp.1</bold> was\nstudied on 4T1 breast cancer BALB/c mice model. The intratumor treatment\nof 5-Fu-loaded <bold>cp.1</bold> demonstrated beneficial antitumor\nefficacy by postponing tumor growth. These results suggest that the\n5-Fu-loaded <bold>cp.1</bold> microparticles with a great locoregional\ndelivery can be efficient anticancer drug carriers for further clinical\ntreatments.</p>", "clean_text": "Designable coordination polymers with suitable chemical diversities and biocompatible structures have been proposed as a promising class of vehicles for drug delivery systems. Here, we hydrothermally synthesized a novel one-dimensional (1D) coordination polymer, [Zn(H2O)6K2(H2BTC)2(H2O)4](H2BTC)2\u22c52H2O, where H3BTC = benzene-1,3,5-tricarboxylic acid (trimesic acid), cp.1. As the hydrogen bonds stabilized 1D chains in three dimensions, the cp.1 could be a good candidate for delivering small-molecule chemotherapeutics such as 5-fluorouracil (5-Fu). The synthesized cp.1 showed a remarkable 5-Fu loading of 66% with encapsulation efficiency of 98% and almost complete release process. The 5-Fu-loaded cp.1 displayed a time-dependent cytotoxicity effect against breast cancer cell lines MCF-7 and 4T1. The cellular uptake of cp.1 particles was investigated via confocal laser scanning microscopy using fluorescein isothiocyanate and LysoTracker Red staining. Furthermore, the in vivo antitumor impact of 5-Fu-loaded cp.1 was studied on 4T1 breast cancer BALB/c mice model. The intratumor treatment of 5-Fu-loaded cp.1 demonstrated beneficial antitumor efficacy by postponing tumor growth. These results suggest that the 5-Fu-loaded cp.1 microparticles with a great locoregional delivery can be efficient anticancer drug carriers for further clinical treatments.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>Coordination compounds with unbounded\nstructures, constructed from metal (as inorganic part) and ligand\n(as organic part), have been severely studied. In 1960s, the term\nof coordination polymers appeared and was reviewed as the versatile\ncompounds. These inorganic\u2013organic hybrid materials are a potent\nand applicable category of materials with desired architecture in\naccordance with the specific application. Assembly of different building blocks, such as diverse metals and\nlinkers, causes the formation of different porosities, including one-dimensional\n(1D), two-dimensional, and three-dimensional networks. Therefore, these highly desirable compounds can be applied\nin various areas, including catalysis, gas storage, gas separation, imaging, sensing, and more importantly as drug carriers.\n</p>", "clean_text": "Introduction\n\nCoordination compounds with unbounded structures, constructed from metal (as inorganic part) and ligand (as organic part), have been severely studied. In 1960s, the term of coordination polymers appeared and was reviewed as the versatile compounds. These inorganic-organic hybrid materials are a potent and applicable category of materials with desired architecture in accordance with the specific application. Assembly of different building blocks, such as diverse metals and linkers, causes the formation of different porosities, including one-dimensional (1D), two-dimensional, and three-dimensional networks. Therefore, these highly desirable compounds can be applied in various areas, including catalysis, gas storage, gas separation, imaging, sensing, and more importantly as drug carriers. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<p>Over the past 3 decades, various types of nanocarriers, such\nas diverse metal oxides, micelles, conventional inorganic nanostructures, and carbon-type carriers, e.g., carbon nanotubes and graphene oxide, have been\nmade and investigated. Moreover, it has been proved that use of micron-sized\ndelivery systems, such as microvectors, microcapsules, microspheres, and mesoporous silicon microparticles, can be a good approach for drug delivery. In\na new perspective, coordination polymers, as a novel classification\nof carriers with a substantial loading capability, have been introduced. Microscale and nanoscale coordination polymers have demonstrated\ninimitable advantages in drug delivery systems. These advantages are\nnontoxic, well-controlled drug release behavior and stability, which\ncan be the most pivotal characteristics of every efficient carriers. These mentioned properties make coordination\npolymers one of the most applicable carriers in anticancer drug delivery\nsystems.\n</p>", "clean_text": "Over the past 3 decades, various types of nanocarriers, such as diverse metal oxides, micelles, conventional inorganic nanostructures, and carbon-type carriers, e.g., carbon nanotubes and graphene oxide, have been made and investigated. Moreover, it has been proved that use of micron-sized delivery systems, such as microvectors, microcapsules, microspheres, and mesoporous silicon microparticles, can be a good approach for drug delivery. In a new perspective, coordination polymers, as a novel classification of carriers with a substantial loading capability, have been introduced. Microscale and nanoscale coordination polymers have demonstrated inimitable advantages in drug delivery systems. These advantages are nontoxic, well-controlled drug release behavior and stability, which can be the most pivotal characteristics of every efficient carriers. These mentioned properties make coordination polymers one of the most applicable carriers in anticancer drug delivery systems. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>5-Fluorouracil (5-Fu), an antimetabolite\nof the pyrimidine analogue type, has been applied as an anticancer\nagent against several cancers, such as colon, pancreas, liver, breast,\ngastrointestinal tract, brain, rectum, etc. for decades. Regarding the 5-Fu structure, it impedes nucleoside metabolism and\ncan be incorporated into DNA and RNA, causing cell death. Using 5-Fu alone or in combination with chemotherapy\nregimens, as many other cytotoxic anticancer drugs, is associated\nwith some significant challenges: (i) short biological half-life,\nleading to the implementation of high drug doses and (ii) toxic side\neffects like hair loss, exhaustion, and liver disorders due to lack\nof specificity in its systemic biodistribution. The drug resistance of tumor cells, which is observed during\nthe past decades, is one of the major reasons that have extensively\nrestricted 5-Fu clinical applications. These unfavorable properties frequently cause treatment failures,\nespecially in patients with malignancies who are more sensitive to\nchemotherapeutic agents, for instance, breast cancer. Thus, the 5-Fu delivery was studied by a large number of\ngroups who investigated various complicated formulations to improve\nthe 5-Fu delivery in the simulated body fluids.\n</p>", "clean_text": "5-Fluorouracil (5-Fu), an antimetabolite of the pyrimidine analogue type, has been applied as an anticancer agent against several cancers, such as colon, pancreas, liver, breast, gastrointestinal tract, brain, rectum, etc. for decades. Regarding the 5-Fu structure, it impedes nucleoside metabolism and can be incorporated into DNA and RNA, causing cell death. Using 5-Fu alone or in combination with chemotherapy regimens, as many other cytotoxic anticancer drugs, is associated with some significant challenges: (i) short biological half-life, leading to the implementation of high drug doses and (ii) toxic side effects like hair loss, exhaustion, and liver disorders due to lack of specificity in its systemic biodistribution. The drug resistance of tumor cells, which is observed during the past decades, is one of the major reasons that have extensively restricted 5-Fu clinical applications. These unfavorable properties frequently cause treatment failures, especially in patients with malignancies who are more sensitive to chemotherapeutic agents, for instance, breast cancer. Thus, the 5-Fu delivery was studied by a large number of groups who investigated various complicated formulations to improve the 5-Fu delivery in the simulated body fluids. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<p>Therefore, designing a simple novel carrier with an astonishing\nloading capacity and complete delivery, including active or passive\napproach, can be very helpful in this area.</p><p>In this study, we\nfocused on the design and synthesis of a new microscale coordination\npolymer utilizing both covalent and hydrogen bonds. To achieve the\nbiocompatible network, we applied zinc\u00ad(II) nitrate as a metal source,\ntrimesic acid as a biodegradable linker, and potassium hydroxide as\na base. The attractive point of this work is the formation of a 1D\nnovel coordination polymer consisting of two kinds of biocompatible\ndivalent (Zn) and monovalent (K) metals in which all of the chains\nare strongly connected by hydrogen bonds (<bold>cp.1</bold>). In the\nnext step, we applied 5-Fu as a globally applicable anti-breast cancer\ndrug and investigated the loading and release process of this small\nmolecule in appropriate media. Regarding the high 5-Fu loading and\napproximately complete drug release, we studied the in vitro performance\nof the novel carrier against mouse mammary carcinoma cell line (4T1)\nand human breast cancer cell line (MCF-7). Consequently, we investigated\nantitumoral activities of 5-Fu-loaded <bold>cp.1</bold> on breast\ncancer BALB/c mouse model to gain comprehensive knowledge about the\nproficiency of the synthesized carrier ().</p>", "clean_text": "Therefore, designing a simple novel carrier with an astonishing loading capacity and complete delivery, including active or passive approach, can be very helpful in this area.\n\nIn this study, we focused on the design and synthesis of a new microscale coordination polymer utilizing both covalent and hydrogen bonds. To achieve the biocompatible network, we applied zinc(II) nitrate as a metal source, trimesic acid as a biodegradable linker, and potassium hydroxide as a base. The attractive point of this work is the formation of a 1D novel coordination polymer consisting of two kinds of biocompatible divalent (Zn) and monovalent (K) metals in which all of the chains are strongly connected by hydrogen bonds (cp.1). In the next step, we applied 5-Fu as a globally applicable anti-breast cancer drug and investigated the loading and release process of this small molecule in appropriate media. Regarding the high 5-Fu loading and approximately complete drug release, we studied the in vitro performance of the novel carrier against mouse mammary carcinoma cell line (4T1) and human breast cancer cell line (MCF-7). Consequently, we investigated antitumoral activities of 5-Fu-loaded cp.1 on breast cancer BALB/c mouse model to gain comprehensive knowledge about the proficiency of the synthesized carrier ().", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Schematic Illustration<xref ref-type=\"fn\" rid=\"s1fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr1\" position=\"float\" xlink:href=\"am-2018-031116_0011.tif\"></graphic>\n<p>\n<fn id=\"s1fn1\">\n<label>a</label>\n<p>Schematic illustration of (a) hydrothermal synthesis of <bold>cp.1</bold> using Zn<sup>2+</sup>, K<sup>+</sup>, and 1,3,5-BTC; (b) 5-Fu loading\nprocess; and (c) drug release from 5-Fu-loaded <bold>cp.1</bold> during\n72 h, which was associated with collapse of crystalline structure\nof the synthesized <bold>cp.1</bold>.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 1  Schematic Illustration      a Schematic illustration of (a) hydrothermal synthesis of cp.1 using Zn2+, K+, and 1,3,5-BTC; (b) 5-Fu loading process; and (c) drug release from 5-Fu-loaded cp.1 during 72 h, which was associated with collapse of crystalline structure of the synthesized cp.1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 7, "type": "text", "classification": ["else"], "content": "<p>\n<fn id=\"s1fn1\">\n<label>a</label>\n<p>Schematic illustration of (a) hydrothermal synthesis of <bold>cp.1</bold> using Zn<sup>2+</sup>, K<sup>+</sup>, and 1,3,5-BTC; (b) 5-Fu loading\nprocess; and (c) drug release from 5-Fu-loaded <bold>cp.1</bold> during\n72 h, which was associated with collapse of crystalline structure\nof the synthesized <bold>cp.1</bold>.</p>\n</fn>\n</p>", "clean_text": "  a Schematic illustration of (a) hydrothermal synthesis of cp.1 using Zn2+, K+, and 1,3,5-BTC; (b) 5-Fu loading process; and (c) drug release from 5-Fu-loaded cp.1 during 72 h, which was associated with collapse of crystalline structure of the synthesized cp.1.  ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 8, "type": "text", "classification": ["else"], "content": "<title>Material and Methods</title><title>Materials</title><p>All employed reagents\nand solvents were of analytical grade purity, purchased from commercial\nsources and used as received. Zn\u00ad(NO<sub>3</sub>)<sub>2</sub>\u00b76H<sub>2</sub>O (Merck), 1,3,5-benzenetricarboxylic acid (1,3,5-H<sub>3</sub>BTC), KOH, 5-Fu, dimethyl sulfoxide (DMSO), and formaldehyde were\nall purchased from Merck (Merck, MA). LysoTracker Red DND-99 was purchased\nfrom Thermo Fisher (MA), and fetal bovine serum (FBS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium\nbromide (MTT), penicillin, 0.25% trypsin\u2013ethylenediaminetetraacetic\nacid (EDTA), Dulbecco\u2019s modified Eagle\u2019s medium (DMEM)\ncell culture medium, 4\u2032,6-diamidino-2-phenylindole (DAPI),\nfluorescein isothiocyanate (FITC) were all purchased from Sigma-Aldrich\n(MO). 4T1, mouse mammary breast cancer cell line and MCF-7, human\nbreast cancer cell line were obtained from National Cell Bank of Iran\n(Pasteur Institute of Iran, Tehran, Iran).</p>", "clean_text": "Material and Methods\n\nMaterials\n\nAll employed reagents and solvents were of analytical grade purity, purchased from commercial sources and used as received. Zn(NO3)2\u22c56H2O (Merck), 1,3,5-benzenetricarboxylic acid (1,3,5-H3BTC), KOH, 5-Fu, dimethyl sulfoxide (DMSO), and formaldehyde were all purchased from Merck (Merck, MA). LysoTracker Red DND-99 was purchased from Thermo Fisher (MA), and fetal bovine serum (FBS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), penicillin, 0.25% trypsin-ethylenediaminetetraacetic acid (EDTA), Dulbecco's modified Eagle's medium (DMEM) cell culture medium, 4',6-diamidino-2-phenylindole (DAPI), fluorescein isothiocyanate (FITC) were all purchased from Sigma-Aldrich (MO). 4T1, mouse mammary breast cancer cell line and MCF-7, human breast cancer cell line were obtained from National Cell Bank of Iran (Pasteur Institute of Iran, Tehran, Iran).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 9, "type": "text", "classification": ["else"], "content": "<title>Instrumentation</title><p>The quantitative determination of 5-Fu concentration in either loading\nor release process was accomplished by UV\u2013visible spectrophotometry\n(CECIL 7500, U.K.). The \u03b6-potential of the synthesized and loaded\nmicroparticles was measured by dynamic light scattering method using\na Malvern Nano ZS, Zetasizer, U.K. The morphology of particles was\nobserved by field emission scanning electron microscopy (FE-SEM) using\na HITACHI S-4160 apparatus, Japan. Fourier transform infrared (FT-IR)\nspectra were recorded using a Bruker, Equinox 55 spectrometer equipped\nwith an attenuated total reflectance accessory over the range of 600\u20134000\ncm<sup>\u20131</sup>. Single-crystal X-ray diffraction (SXRD) measurement\nfor <bold>cp.1</bold> was performed on a four-circle \u03ba geometry\nKUMA KM-4 diffractometer equipped with a two-dimensional area charge-coupled\ndevice detector, using graphite monochromatic Mo K\u03b1 (\u03bb\n= 0.71073 \u00c5) radiation. Powder X-ray diffraction (PXRD) was performed\nby Philips, PW1730 with 2\u03b8 range of 2\u201320\u00b0, with\n0.02\u00b0 step width and wavelength of Cu K\u03b1 (\u03bb = 1.5409\n\u00c5). Thermogravimetric analysis (TGA) of dried synthesized compound\n(5\u20136 mg) was performed in an argon atmosphere in the temperature\nrange 20\u2013600 \u00b0C with a heating ramp of 20 \u00b0C/min\nusing a thermal analyzer (TA, TGA Q50). The cellular uptake of FITC-loaded <bold>cp.1</bold> was investigated by confocal laser scanning microscopy\n(CLSM; Nikon Eclipse Ti, Japan).</p>", "clean_text": "Instrumentation\n\nThe quantitative determination of 5-Fu concentration in either loading or release process was accomplished by UV-visible spectrophotometry (CECIL 7500, U.K.). The \u03b6-potential of the synthesized and loaded microparticles was measured by dynamic light scattering method using a Malvern Nano ZS, Zetasizer, U.K. The morphology of particles was observed by field emission scanning electron microscopy (FE-SEM) using a HITACHI S-4160 apparatus, Japan. Fourier transform infrared (FT-IR) spectra were recorded using a Bruker, Equinox 55 spectrometer equipped with an attenuated total reflectance accessory over the range of 600-4000 cm-1. Single-crystal X-ray diffraction (SXRD) measurement for cp.1 was performed on a four-circle \u03ba geometry KUMA KM-4 diffractometer equipped with a two-dimensional area charge-coupled device detector, using graphite monochromatic Mo K\u03b1 (\u03bb = 0.71073 \u00c5) radiation. Powder X-ray diffraction (PXRD) was performed by Philips, PW1730 with 2\u03b8 range of 2-20\u00b0, with 0.02\u00b0 step width and wavelength of Cu K\u03b1 (\u03bb = 1.5409 \u00c5). Thermogravimetric analysis (TGA) of dried synthesized compound (5-6 mg) was performed in an argon atmosphere in the temperature range 20-600 \u00b0C with a heating ramp of 20 \u00b0C/min using a thermal analyzer (TA, TGA Q50). The cellular uptake of FITC-loaded cp.1 was investigated by confocal laser scanning microscopy (CLSM; Nikon Eclipse Ti, Japan).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 10, "type": "text", "classification": ["else"], "content": "<title>Animals</title><p>The mice\nused in the research were obtained from Royan Institute; 15 female\nBALB/c syngeneic mice (21\u201323 g) were housed under ambient temperature\nand standard diet. The study was conducted according to the ethical\nguidelines approved by the ethical committee of Pharmaceutical Research\nCenter, Faculty of Pharmacy, Tehran University of Medical Sciences,\nwhich are based on the NIH guide for the care and use of laboratory\nanimals.</p>", "clean_text": "Animals\n\nThe mice used in the research were obtained from Royan Institute; 15 female BALB/c syngeneic mice (21-23 g) were housed under ambient temperature and standard diet. The study was conducted according to the ethical guidelines approved by the ethical committee of Pharmaceutical Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, which are based on the NIH guide for the care and use of laboratory animals.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 11, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of Compound [Zn\u00ad(H<sub>2</sub>O)<sub>6</sub>K<sub>2</sub>(H<sub>2</sub>BTC)<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>]\u00ad(H<sub>2</sub>BTC)<sub>2</sub>\u00b72H<sub>2</sub>O <bold>(cp.1)</bold>\n</title><p>A mixture of Zn\u00ad(NO<sub>3</sub>)<sub>2</sub>\u00b76H<sub>2</sub>O (0.1 mmol), H<sub>3</sub>BTC (0.3 mmol), KOH (0.5 mmol), and H<sub>2</sub>O (5 mL) was placed in a Teflon-lined autoclave. It was held\nat 200 \u00b0C for 3 days with cooling ramp of 96 h. In the purification\nstep, the colorless needle crystals were centrifuged, washed with\nfresh distilled water three times, and then dried at room temperature.</p>", "clean_text": "Synthesis of Compound [Zn(H2O)6K2(H2BTC)2(H2O)4](H2BTC)2\u22c52H2O (cp.1) \n\nA mixture of Zn(NO3)2\u22c56H2O (0.1 mmol), H3BTC (0.3 mmol), KOH (0.5 mmol), and H2O (5 mL) was placed in a Teflon-lined autoclave. It was held at 200 \u00b0C for 3 days with cooling ramp of 96 h. In the purification step, the colorless needle crystals were centrifuged, washed with fresh distilled water three times, and then dried at room temperature.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 12, "type": "text", "classification": ["else"], "content": "<p>The structure was solved by the direct method using SHELXS-97 and\nrefined by the SHELXL-2014/7 program. All nonhydrogen atoms were refined\nusing anisotropic thermal parameters. Visualization of the structure\nwas made by the Diamond 3.1 program. Crystallographic\ndata for the structure have been deposited in the Cambridge Crystallographic\nData Center with CCDC number: 1530592. The detailed crystallographic\ndata and structure refinement parameters for <bold>cp.1</bold> are\nsummarized in <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">Table S1</ext-link>. Additionally, synthesized <bold>cp.1</bold> compound was characterized by PXRD, FT-IR, TGA, and \u03b6-potential\nmeasurement.</p>", "clean_text": "The structure was solved by the direct method using SHELXS-97 and refined by the SHELXL-2014/7 program. All nonhydrogen atoms were refined using anisotropic thermal parameters. Visualization of the structure was made by the Diamond 3.1 program. Crystallographic data for the structure have been deposited in the Cambridge Crystallographic Data Center with CCDC number: 1530592. The detailed crystallographic data and structure refinement parameters for cp.1 are summarized in Table S1. Additionally, synthesized cp.1 compound was characterized by PXRD, FT-IR, TGA, and \u03b6-potential measurement.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 13, "type": "text", "classification": ["else"], "content": "<title>5-Fu Impregnation Process</title><p>5-Fu (5\nmg) was completely dissolved in 4 mL of distilled water, followed\nby addition of 2.5 mg of synthesized <bold>cp.1</bold>. The prepared\nsuspension was then sealed and stirred (650 rpm) for 24 h at room\ntemperature. After all, the 5-Fu-loaded <bold>cp.1</bold> particles\nwere filtered under vacuum with a 0.2 \u03bcm cellulose acetate (Whatman\nCA) membrane filter. The loaded particles were dried overnight. The\nunloaded drug concentration in clear supernatant was then quantified\nby UV\u2013vis spectrophotometry at \u03bb<sub>max</sub> = 266\nnm in triplicates.</p>", "clean_text": "5-Fu Impregnation Process\n\n5-Fu (5 mg) was completely dissolved in 4 mL of distilled water, followed by addition of 2.5 mg of synthesized cp.1. The prepared suspension was then sealed and stirred (650 rpm) for 24 h at room temperature. After all, the 5-Fu-loaded cp.1 particles were filtered under vacuum with a 0.2 \u03bcm cellulose acetate (Whatman CA) membrane filter. The loaded particles were dried overnight. The unloaded drug concentration in clear supernatant was then quantified by UV-vis spectrophotometry at \u03bbmax = 266 nm in triplicates.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 14, "type": "text", "classification": "error", "content": "<p>In addition, 5-Fu-loaded particles were characterized\nby PXRD, FT-IR, and \u03b6-potential measurement to determine the\nchanges after the loading process.</p><title>In Vitro 5-Fu Release Study</title><p>5-Fu release from the synthesized <bold>cp.1</bold> particles was\nstudied through suspending 1 mg/mL of 5-Fu-loaded <bold>cp.1</bold> in 10% FBS solution. The suspension was kept under rotative agitation\nfor different incubation times (45 min to 4 days). At each time interval,\nthe release medium was recovered by centrifugation (14\u2009000\nrpm, 10 min) and replaced with 1 mL of fresh medium. When the experiment\nwas finished, all media were centrifuged again (20\u2009000 rpm,\n10 min) to collect any residual particles. Finally, the concentration\nof the released 5-Fu at each time was quantified by UV\u2013visible\nspectrophotometry at \u03bb<sub>max</sub> = 296 nm. The experiments\nwere performed in triplicates.</p>", "clean_text": "In addition, 5-Fu-loaded particles were characterized by PXRD, FT-IR, and \u03b6-potential measurement to determine the changes after the loading process.\n\nIn Vitro 5-Fu Release Study\n\n5-Fu release from the synthesized cp.1 particles was studied through suspending 1 mg/mL of 5-Fu-loaded cp.1 in 10% FBS solution. The suspension was kept under rotative agitation for different incubation times (45 min to 4 days). At each time interval, the release medium was recovered by centrifugation (14000 rpm, 10 min) and replaced with 1 mL of fresh medium. When the experiment was finished, all media were centrifuged again (20000 rpm, 10 min) to collect any residual particles. Finally, the concentration of the released 5-Fu at each time was quantified by UV-visible spectrophotometry at \u03bbmax = 296 nm. The experiments were performed in triplicates.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 15, "type": "text", "classification": ["else"], "content": "<title>Cell Culture Experiments</title><p>The cells MCF-7 and 4T1 as human and mouse breast cancer cell lines,\nrespectively, were used for in vitro cytotoxicity assay. DMEM supplemented\nwith 10% FBS and 5% penicillin\u2013streptomycin was utilized as\nthe cell culture medium. Before the experiment, cells were cultivated\nin a humidified environment at 37 \u00b0C with 5% CO<sub>2</sub> to\nreach desirable confluence. Afterward, the cells were detached from\nthe flask using trypsin\u2013EDTA, collected by centrifugation (1500\nrpm, 5 min), resuspended in culture media, counted, and used for further\ncell culture studies.</p>", "clean_text": "Cell Culture Experiments\n\nThe cells MCF-7 and 4T1 as human and mouse breast cancer cell lines, respectively, were used for in vitro cytotoxicity assay. DMEM supplemented with 10% FBS and 5% penicillin-streptomycin was utilized as the cell culture medium. Before the experiment, cells were cultivated in a humidified environment at 37 \u00b0C with 5% CO2 to reach desirable confluence. Afterward, the cells were detached from the flask using trypsin-EDTA, collected by centrifugation (1500 rpm, 5 min), resuspended in culture media, counted, and used for further cell culture studies.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 16, "type": "text", "classification": ["else"], "content": "<title>Cellular Uptake Studies</title><p>FITC fluorescent\ndye was used for labeling the <bold>cp.1</bold> particles, and the\nprotocol involves the overnight incubation of FITC (100 nM) with <bold>cp.1</bold> particles in the dark. The unloaded FITC was removed\nby centrifugation (14\u2009000 rpm, 5 min).</p>", "clean_text": "Cellular Uptake Studies\n\nFITC fluorescent dye was used for labeling the cp.1 particles, and the protocol involves the overnight incubation of FITC (100 nM) with cp.1 particles in the dark. The unloaded FITC was removed by centrifugation (14000 rpm, 5 min).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 17, "type": "text", "classification": ["else"], "content": "<p>For cellular internalization\nprocess, MCF-7 cells were seeded in glass dishes with a density of\n80\u2009000\u2013100\u2009000 cells. After 24 h, the cells were\ntreated with FITC-loaded <bold>cp.1</bold> particles (10 \u03bcg/mL)\nfor 3 h. For lysosome detection, the cells were incubated with LysoTracker\nRed (300 nM) for 1 h. The cells were washed by phosphate-buffered\nsaline (PBS) three times and then fixed by 4% paraformaldehyde for\n4 min. Cells were then stained with DAPI for 5 min and washed three\ntimes with PBS. Confocal microscopy was performed on a FluoView in\na sequential scanning mode using a 20\u201340\u00d7 objective.</p>", "clean_text": "For cellular internalization process, MCF-7 cells were seeded in glass dishes with a density of 80000-100000 cells. After 24 h, the cells were treated with FITC-loaded cp.1 particles (10 \u03bcg/mL) for 3 h. For lysosome detection, the cells were incubated with LysoTracker Red (300 nM) for 1 h. The cells were washed by phosphate-buffered saline (PBS) three times and then fixed by 4% paraformaldehyde for 4 min. Cells were then stained with DAPI for 5 min and washed three times with PBS. Confocal microscopy was performed on a FluoView in a sequential scanning mode using a 20-40\u00d7 objective.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 18, "type": "text", "classification": "error", "content": "<title>MTT Assay</title><p>The cytotoxicity of 5-Fu as free drug, synthesized <bold>cp.1</bold>s, and 5-Fu-loaded <bold>cp.1</bold>s, was investigated\nagainst MCF-7 and 4T1 cells by MTT assay. For this measurement, the\ncells were seeded into 96-well plates at about 8000\u201310\u2009000\ncells per well. At first, the cells were incubated for 24 h. Then,\ncell treatment was performed at the drug concentration range of 0.01,\n0.1, 0.5, 1, 10, 50, and 100 \u03bcg/mL. According to the 5-Fu release\nprofile, the cells were incubated for 24, 48, and 72 h at 37 \u00b0C\nand 5% CO<sub>2</sub>. After each time interval, the old medium was\nreplaced with 50 \u03bcL of MTT/PBS solution (0.5 mg/mL). The plates\nwere incubated for 2\u20134 h at 37 \u00b0C and 5% CO<sub>2</sub>. Afterward, DMSO was added to each well to dissolve the purple insoluble\nformazan crystals. Eventually, the absorbance of the solution was\nquantified by a microplate reader (BioTEK ELX800) at the wavelengths\nof 570 and 630 nm as reference.</p>", "clean_text": "MTT Assay\n\nThe cytotoxicity of 5-Fu as free drug, synthesized cp.1s, and 5-Fu-loaded cp.1s, was investigated against MCF-7 and 4T1 cells by MTT assay. For this measurement, the cells were seeded into 96-well plates at about 8000-10000 cells per well. At first, the cells were incubated for 24 h. Then, cell treatment was performed at the drug concentration range of 0.01, 0.1, 0.5, 1, 10, 50, and 100 \u03bcg/mL. According to the 5-Fu release profile, the cells were incubated for 24, 48, and 72 h at 37 \u00b0C and 5% CO2. After each time interval, the old medium was replaced with 50 \u03bcL of MTT/PBS solution (0.5 mg/mL). The plates were incubated for 2-4 h at 37 \u00b0C and 5% CO2. Afterward, DMSO was added to each well to dissolve the purple insoluble formazan crystals. Eventually, the absorbance of the solution was quantified by a microplate reader (BioTEK ELX800) at the wavelengths of 570 and 630 nm as reference.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 19, "type": "text", "classification": "error", "content": "<title>Tumor Treatment and in\nVivo Evaluation of Antitumor Efficacy</title><p>Mouse tumor models\nof mammary breast cancer 4T1 were established by injecting 2 \u00d7\n10<sup>6</sup> of tumor cells subcutaneously into the mammary gland\nof 4 week old mice. The treatment was started on the 10th day after\ntumor cell transplantation when 80% of the tumors reached a volume\nof 150\u2013200 mm<sup>3</sup>. The mice were randomly divided into\nthree groups, which were named as 5-Fu (free drug), 5-Fu.<bold>cp.1</bold> (5-Fu-loaded <bold>cp.1</bold>), and control (untreated group),\nand each group contained five mice. On day 0 (the day was designated\nas \u201cday 0\u201d), two groups of the mice (5-Fu and 5-Fu.<bold>cp.1</bold>) were intratumorally (it) treated with a dose normalized\nto be equivalent to 11 mg/kg 5-Fu, which was given once. Tumor growth\nwas followed every 3 days by measuring two tumor diameters (<italic>D</italic> and <italic>d</italic> were the longest and the shortest\ndiameters of the tumors in millimeters, respectively) with a caliper,\nand the tumor volume was calculated by the formula <italic>V</italic> = <italic>D</italic> \u00d7 <italic>d</italic>\n<sup>2</sup>/2.\n</p>", "clean_text": "Tumor Treatment and in Vivo Evaluation of Antitumor Efficacy\n\nMouse tumor models of mammary breast cancer 4T1 were established by injecting 2 \u00d7 106 of tumor cells subcutaneously into the mammary gland of 4 week old mice. The treatment was started on the 10th day after tumor cell transplantation when 80% of the tumors reached a volume of 150-200 mm3. The mice were randomly divided into three groups, which were named as 5-Fu (free drug), 5-Fu.cp.1 (5-Fu-loaded cp.1), and control (untreated group), and each group contained five mice. On day 0 (the day was designated as \"day 0\"), two groups of the mice (5-Fu and 5-Fu.cp.1) were intratumorally (it) treated with a dose normalized to be equivalent to 11 mg/kg 5-Fu, which was given once. Tumor growth was followed every 3 days by measuring two tumor diameters (D and d were the longest and the shortest diameters of the tumors in millimeters, respectively) with a caliper, and the tumor volume was calculated by the formula V = D \u00d7 d 2/2. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 20, "type": "text", "classification": "error", "content": "<title>Histological Analysis</title><p>The animals were euthanized 28 days\npost-treatment, and the harvested mammary glands were fixed in 10%\nneutral-buffered formalin (pH 7.26) for 48 h, then processed, and\nembedded in paraffin. Thick sections (5 \u03bcm) were prepared and\nstained with hematoxylin and eosin (H&amp;E). The histological slides\nwere evaluated by an independent reviewer using light microscopy (Olympus,\nJapan). Histopathological evaluation was performed using Nottingham\nhistologic grading system (Elston\u2013Ellis modification of Scarff\u2013Bloom\u2013Richardson\ngrading system) for breast cancer. This\nscoring system grades the malignancy of breast tumor between 3 and\n9 based on the following features: the amount of gland formation (acinar\nor tubular differentiation), the nuclear features (pleomorphism),\nand the mitotic activity, which were scaled from 1 to 3. Tumors with\na sum of 3\u20135 were considered as grade 1 (well differentiated).\nTumors with a sum of 6\u20137 and 8\u20139 were considered as\ngrade 2 (moderately differentiated) and grade 3 (poorly differentiated),\nrespectively. Moreover, any changes, including inflammatory response,\ncoagulative necrosis, hemorrhage, and hyperemia, were assessed in\ntumor samples, comparatively.</p>", "clean_text": "Histological Analysis\n\nThe animals were euthanized 28 days post-treatment, and the harvested mammary glands were fixed in 10% neutral-buffered formalin (pH 7.26) for 48 h, then processed, and embedded in paraffin. Thick sections (5 \u03bcm) were prepared and stained with hematoxylin and eosin (H&E). The histological slides were evaluated by an independent reviewer using light microscopy (Olympus, Japan). Histopathological evaluation was performed using Nottingham histologic grading system (Elston-Ellis modification of Scarff-Bloom-Richardson grading system) for breast cancer. This scoring system grades the malignancy of breast tumor between 3 and 9 based on the following features: the amount of gland formation (acinar or tubular differentiation), the nuclear features (pleomorphism), and the mitotic activity, which were scaled from 1 to 3. Tumors with a sum of 3-5 were considered as grade 1 (well differentiated). Tumors with a sum of 6-7 and 8-9 were considered as grade 2 (moderately differentiated) and grade 3 (poorly differentiated), respectively. Moreover, any changes, including inflammatory response, coagulative necrosis, hemorrhage, and hyperemia, were assessed in tumor samples, comparatively.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 21, "type": "text", "classification": ["else"], "content": "<title>Statistical Analysis</title><p>All results were expressed as the mean \u00b1 standard deviation\nfrom four individual experiments. Statistical analysis was accomplished\nusing one-way analysis of variance (ANOVA) test. The half-maximal\ninhibitory concentrations (IC<sub>50</sub>) and <italic>P</italic> value were obtained using the SigmaPlot software, and <italic>P</italic> &lt; 0.001 was considered as significant difference.</p>", "clean_text": "Statistical Analysis\n\nAll results were expressed as the mean \u00b1 standard deviation from four individual experiments. Statistical analysis was accomplished using one-way analysis of variance (ANOVA) test. The half-maximal inhibitory concentrations (IC50) and P value were obtained using the SigmaPlot software, and P < 0.001 was considered as significant difference.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 22, "type": "text", "classification": ["else"], "content": "<title>Results\nand Discussion</title><title>Crystal Structure of [Zn\u00ad(H<sub>2</sub>O)<sub>6</sub>K<sub>2</sub>(H<sub>2</sub>BTC)<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>]\u00ad(H<sub>2</sub>BTC)<sub>2</sub>\u00b72H<sub>2</sub>O</title><p>We could obtain single-rodlike colorless crystals by hydrothermal\nmethod (crystallographic details are given in <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">Table S1</ext-link>). The asymmetric unit contains one Zn<sup>2+</sup> (in 2c special position), one K<sup>+</sup> (in 4e general position),\ntwo H<sub>2</sub>BTC<sup>\u2013</sup> (in 4e general position),\nand six water molecules (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">Figure S1</ext-link>). Every\nZn\u00ad(H<sub>2</sub>O)<sub>6</sub>\n<sup>2+</sup> entity is connected to\ntwo K<sup>+</sup> ions by six bridged water oxygen atoms. The potassium\nions constructed one-dimensional chain along <italic>b</italic> axis.\nEach K<sup>+</sup> ion was connected to seven oxygen atoms, two from\nwater, three bridged water atoms from Zn\u00ad(H<sub>2</sub>O)<sub>6</sub>\n<sup>2+</sup>, and two more from two different H<sub>2</sub>BTC<sup>\u2013</sup> ions in a distorted monocapped octahedral geometry,\nsee .</p>", "clean_text": "Results and Discussion\n\nCrystal Structure of [Zn(H2O)6K2(H2BTC)2(H2O)4](H2BTC)2\u22c52H2O\n\nWe could obtain single-rodlike colorless crystals by hydrothermal method (crystallographic details are given in Table S1). The asymmetric unit contains one Zn2+ (in 2c special position), one K+ (in 4e general position), two H2BTC- (in 4e general position), and six water molecules (Figure S1). Every Zn(H2O)6 2+ entity is connected to two K+ ions by six bridged water oxygen atoms. The potassium ions constructed one-dimensional chain along b axis. Each K+ ion was connected to seven oxygen atoms, two from water, three bridged water atoms from Zn(H2O)6 2+, and two more from two different H2BTC- ions in a distorted monocapped octahedral geometry, see .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Oak Ridge thermal\nellipsoid plot view of [Zn\u00ad(H<sub>2</sub>O)<sub>6</sub>K<sub>2</sub>(H<sub>2</sub>BTC)<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>]\u00ad(H<sub>2</sub>BTC)<sub>2</sub>\u00b72H<sub>2</sub>O, <bold>cp.1</bold>,\nwith the labeled atom scheme and displacement of ellipsoids.</p>\n</caption>\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"am-2018-031116_0013.tif\"></graphic>\n</fig>", "clean_text": " 1  Oak Ridge thermal ellipsoid plot view of [Zn(H2O)6K2(H2BTC)2(H2O)4](H2BTC)2\u22c52H2O, cp.1, with the labeled atom scheme and displacement of ellipsoids.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 24, "type": "text", "classification": ["else"], "content": "<p>Besides, there were one free water\nmolecule and one H<sub>2</sub>BTC<sup>\u2013</sup> ion in the asymmetric\nunit that held the parallel chains together by relatively strong hydrogen\nbonds and \u03c0\u2013\u03c0 stacking interactions, stabilizing\nthe crystal structure in three-dimensional network (a,b and <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">S2</ext-link>).</p>", "clean_text": "Besides, there were one free water molecule and one H2BTC- ion in the asymmetric unit that held the parallel chains together by relatively strong hydrogen bonds and \u03c0-\u03c0 stacking interactions, stabilizing the crystal structure in three-dimensional network (a,b and S2).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 25, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>View of the packing diagram of <bold>cp.1</bold> along <italic>a</italic> axis (a) and <italic>c</italic> axis (b).</p>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"am-2018-031116_0001.tif\"></graphic>\n</fig>", "clean_text": " 2  View of the packing diagram of cp.1 along a axis (a) and c axis (b).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "text", "classification": ["property"], "content": "<title>5-Fu Loading Process</title><p>5-Fluorouracil\n(5.3 \u00d7 5.0 \u00c5<sup>2</sup>) is a small and widely used anticancer\ndrug, which is applied for treatment of various cancer tumors. The\nloading process with 1:2 ratio of <bold>cp.1</bold>/5-Fu was examined\nin distilled water. The drug loading (DL) and encapsulation efficiency\n(EE) were investigated by UV\u2013vis spectroscopy with the correlation\ncoefficient of <italic>R</italic>\n<sup>2</sup> = 0.999, which were\nobtained as 66.27 \u00b1 2.1 and 98.26 wt %, respectively. The adsorption\nof 5-Fu on the chains of <bold>cp.1</bold> leads to an obvious decrease\nin adsorption intensity (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">Figure S3</ext-link>). This outstanding amount of loading\nmight be due to the small size of 5-Fu molecules and more importantly\nthe existence of host\u2013guest interactions, such as H-bonding\n(between amine groups of 5-Fu and COOH groups of <bold>cp.1</bold>) and \u03c0\u2013\u03c0 stacking between 5-Fu molecule and <bold>cp.1.</bold>\n\n</p>", "clean_text": "5-Fu Loading Process\n\n5-Fluorouracil (5.3 \u00d7 5.0 \u00c52) is a small and widely used anticancer drug, which is applied for treatment of various cancer tumors. The loading process with 1:2 ratio of cp.1/5-Fu was examined in distilled water. The drug loading (DL) and encapsulation efficiency (EE) were investigated by UV-vis spectroscopy with the correlation coefficient of R 2 = 0.999, which were obtained as 66.27 \u00b1 2.1 and 98.26 wt %, respectively. The adsorption of 5-Fu on the chains of cp.1 leads to an obvious decrease in adsorption intensity (Figure S3). This outstanding amount of loading might be due to the small size of 5-Fu molecules and more importantly the existence of host-guest interactions, such as H-bonding (between amine groups of 5-Fu and COOH groups of cp.1) and \u03c0-\u03c0 stacking between 5-Fu molecule and cp.1.  ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 27, "type": "text", "classification": "error", "content": "<p>To the best of our knowledge,\nthe successful 5-Fu loading amount in <bold>cp.1</bold> is not only\ncomparable but also much higher than most of the other reported 5-Fu-loaded\nmicro- and nanocarriers. Herein, there are some examples of examined\nformulations with their loading capacities: nanofibers (2.6 mg/g of\nnanofibers), nanohydrogels (97\u201399.5%), carbon-based nanocarriers such as graphene oxide\n(32.4%), newly synthesized metal\u2013organic\nframeworks (MOFs) (34.32%), (22.5%) and mixed formulated MOFs such as metal\u2013organic\npolyhedra, colloid, MOF; \u223c40%, hollow microsphere with MOF shell; 51%, Fe-MIL-53-NH<sub>2</sub>-FA-5-FAM; 23% and polymeric microspheres (5\u201320%).\n</p>", "clean_text": "To the best of our knowledge, the successful 5-Fu loading amount in cp.1 is not only comparable but also much higher than most of the other reported 5-Fu-loaded micro- and nanocarriers. Herein, there are some examples of examined formulations with their loading capacities: nanofibers (2.6 mg/g of nanofibers), nanohydrogels (97-99.5%), carbon-based nanocarriers such as graphene oxide (32.4%), newly synthesized metal-organic frameworks (MOFs) (34.32%), (22.5%) and mixed formulated MOFs such as metal-organic polyhedra, colloid, MOF; ~40%, hollow microsphere with MOF shell; 51%, Fe-MIL-53-NH2-FA-5-FAM; 23% and polymeric microspheres (5-20%). ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 28, "type": "text", "classification": ["else"], "content": "<p>The drug loading (DL) and encapsulation efficiency (EE) accounts\nwere calculated according to the well-known previously reported formulas\nin which DL was calculated as the percentage of entrapped drug to\nthe total weight of dried particles and EE was accounted as the percentage\nof entrapped drug to the total amount of drug in feed.\n</p>", "clean_text": "The drug loading (DL) and encapsulation efficiency (EE) accounts were calculated according to the well-known previously reported formulas in which DL was calculated as the percentage of entrapped drug to the total weight of dried particles and EE was accounted as the percentage of entrapped drug to the total amount of drug in feed. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 29, "type": "text", "classification": ["else"], "content": "<title>Characterization of Synthesized <bold>cp.1</bold> and 5-Fu-Loaded <bold>cp.1</bold>\n</title><p>Colorless crystals of <bold>cp.1</bold> with the regular rodlike morphology were synthesized\nin water via the facile hydrothermal method. We applied a laboratory\nsieve with mesh 500 (25 \u03bcm) to achieve a uniform particle size\ndistribution, which was confirmed by FE-SEM images in .</p>", "clean_text": "Characterization of Synthesized cp.1 and 5-Fu-Loaded cp.1 \n\nColorless crystals of cp.1 with the regular rodlike morphology were synthesized in water via the facile hydrothermal method. We applied a laboratory sieve with mesh 500 (25 \u03bcm) to achieve a uniform particle size distribution, which was confirmed by FE-SEM images in .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 30, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>FE-SEM images of hydrothermally\nsynthesized <bold>cp.1</bold> before (a, b) and after (c, d) sieving.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"am-2018-031116_0002.tif\"></graphic>\n</fig>", "clean_text": " 3  FE-SEM images of hydrothermally synthesized cp.1 before (a, b) and after (c, d) sieving.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 31, "type": "text", "classification": "error", "content": "<p>\u03b6-Potential of the hydrothermally\nsynthesized <bold>cp.1</bold> was 0.341 \u00b1 3.54 mV (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">Figure S4</ext-link>). This neutral value changed after\n5-Fu loading to 8.10 \u00b1 4.39 mV, which indicates that it is positively\ncharged. This positive value is in agreement with the high loading\nof 5-Fu with cationic nature, which has excess amounts of amine groups\n(NH).\n</p>", "clean_text": "\u03b6-Potential of the hydrothermally synthesized cp.1 was 0.341 \u00b1 3.54 mV (Figure S4). This neutral value changed after 5-Fu loading to 8.10 \u00b1 4.39 mV, which indicates that it is positively charged. This positive value is in agreement with the high loading of 5-Fu with cationic nature, which has excess amounts of amine groups (NH). ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 32, "type": "text", "classification": ["else"], "content": "<p>As shown in a, the FT-IR spectra of <bold>cp.1</bold> reveal that the peaks at 1680 cm<sup>\u20131</sup> correspond\nto C\ue5fbO bands and the peaks around 1430 and 1560 cm<sup>\u20131</sup> are assigned to the stretching vibrations of O\u2013C\u2013O\ngroup. Also, \u03bd\u00ad(ArC\u2013H) at\n682 and 749 cm<sup>\u20131</sup> and \u03bd\u00ad(ArC\ue5fbC) at 1617\ncm<sup>\u20131</sup> are observed as aromatic bending vibrations\nand aromatic stretching vibrations, respectively. Moreover, the various\ntypes of O\u2013H groups, including six water molecules in Zn\u00ad(H<sub>2</sub>O)<sub>6</sub>, four water molecules around K, and two solvated\nwater molecules, in which some of the water molecules are strongly\npolarized, and also protonated COOH groups may cause broadening of\nthe stretching O\u2013H vibrations. The elemental analysis data\nalso support the FT-IR output to confirm successful synthesis of <bold>cp.1</bold>, C<sub>36</sub>H<sub>44</sub>K<sub>2</sub>O<sub>36</sub>Zn: calculated (%): C, 36.14; H, 3.68; found (%): C, 36.56; H, 3.65.</p>", "clean_text": "As shown in a, the FT-IR spectra of cp.1 reveal that the peaks at 1680 cm-1 correspond to C\ue5fbO bands and the peaks around 1430 and 1560 cm-1 are assigned to the stretching vibrations of O-C-O group. Also, \u03bd(ArC-H) at 682 and 749 cm-1 and \u03bd(ArC\ue5fbC) at 1617 cm-1 are observed as aromatic bending vibrations and aromatic stretching vibrations, respectively. Moreover, the various types of O-H groups, including six water molecules in Zn(H2O)6, four water molecules around K, and two solvated water molecules, in which some of the water molecules are strongly polarized, and also protonated COOH groups may cause broadening of the stretching O-H vibrations. The elemental analysis data also support the FT-IR output to confirm successful synthesis of cp.1, C36H44K2O36Zn: calculated (%): C, 36.14; H, 3.68; found (%): C, 36.56; H, 3.65.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 33, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>FT-IR\nspectra of <bold>cp.1</bold> (a, black), 5-Fu-loaded <bold>cp.1</bold> (b, red), and 5-Fu (c, blue).</p>\n</caption>\n<graphic id=\"gr5\" position=\"float\" xlink:href=\"am-2018-031116_0003.tif\"></graphic>\n</fig>", "clean_text": " 4  FT-IR spectra of cp.1 (a, black), 5-Fu-loaded cp.1 (b, red), and 5-Fu (c, blue).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 34, "type": "text", "classification": "error", "content": "<p>The vibrational bands of synthesized <bold>cp.1</bold> around\n727, 782, 1424, 1601, and 1681 cm<sup>\u20131</sup> were all observed\nin the FT-IR spectrum of the 5-Fu-loaded <bold>cp.1</bold> with a\nlittle shift in aromatic bending vibrations of C\u2013H, which might\nbe due to the hydrogen bonding and van der Waals interactions between <bold>cp.1</bold> and 5-Fu. This accordance\nconfirmed the stability of the synthesized <bold>cp.1</bold> after\nloading process without any chemical reaction with 5-Fu molecule.\nAlso, 5-Fu loading in <bold>cp.1</bold> is confirmed by the appearance\nof N\u2013H bending vibration at 654 cm<sup>\u20131</sup> and\nC\u2013F stretching vibration at 1286 cm<sup>\u20131</sup>. Moreover,\ndeformation vibrations of CF\ue5fbCH group was observed at 782 and\n727 cm<sup>\u20131</sup> in 5-Fu after loading, which are shifted\nto the lower stretching frequency because of the host\u2013guest\ninteractions and increase of bond length (b). The\npeaks at 1725, 1654, and 1429 cm<sup>\u20131</sup> are attributed\nto the ketoimide ring structure, enolic form, and C\u2013N stretching\nvibrations in 5-Fu, respectively. Also, the stretching vibration of\nN\u2013H as a broad band was observed at 3135 cm<sup>\u20131\u00a0</sup>\n (c).</p>", "clean_text": "The vibrational bands of synthesized cp.1 around 727, 782, 1424, 1601, and 1681 cm-1 were all observed in the FT-IR spectrum of the 5-Fu-loaded cp.1 with a little shift in aromatic bending vibrations of C-H, which might be due to the hydrogen bonding and van der Waals interactions between cp.1 and 5-Fu. This accordance confirmed the stability of the synthesized cp.1 after loading process without any chemical reaction with 5-Fu molecule. Also, 5-Fu loading in cp.1 is confirmed by the appearance of N-H bending vibration at 654 cm-1 and C-F stretching vibration at 1286 cm-1. Moreover, deformation vibrations of CF\ue5fbCH group was observed at 782 and 727 cm-1 in 5-Fu after loading, which are shifted to the lower stretching frequency because of the host-guest interactions and increase of bond length (b). The peaks at 1725, 1654, and 1429 cm-1 are attributed to the ketoimide ring structure, enolic form, and C-N stretching vibrations in 5-Fu, respectively. Also, the stretching vibration of N-H as a broad band was observed at 3135 cm-1   (c).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 35, "type": "text", "classification": ["else"], "content": "<p>The PXRD pattern of the synthesized <bold>cp.1</bold> is totally in accordance with the simulated XRD pattern and confirmed\nthat the crystalline integrity of the synthesized powder is similar\nto the synthesized single crystal (see a,b). As shown in c,d, loading of 5-Fu causes interspace between\n1D chains and also decreases long-range order of its crystallinity,\nwhich led to shifting and weakening some of Miller indices, respectively.\nOn the other hand, the powder X-ray reflections of 5-Fu-loaded <bold>cp.1</bold> confirmed the successful loading process due to indexing\na strong peak at about 27\u201328\u00b0 2\u03b8.</p>", "clean_text": "The PXRD pattern of the synthesized cp.1 is totally in accordance with the simulated XRD pattern and confirmed that the crystalline integrity of the synthesized powder is similar to the synthesized single crystal (see a,b). As shown in c,d, loading of 5-Fu causes interspace between 1D chains and also decreases long-range order of its crystallinity, which led to shifting and weakening some of Miller indices, respectively. On the other hand, the powder X-ray reflections of 5-Fu-loaded cp.1 confirmed the successful loading process due to indexing a strong peak at about 27-28\u00b0 2\u03b8.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 36, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig5\" position=\"float\">\n<label>5</label>\n<caption>\n<p>PXRD patterns of simulated <bold>cp.1</bold> (a, green), synthesized <bold>cp.1</bold> (b, black),\n5-Fu-loaded <bold>cp.1</bold> (c, red), and 5-Fu (d, blue).</p>\n</caption>\n<graphic id=\"gr6\" position=\"float\" xlink:href=\"am-2018-031116_0004.tif\"></graphic>\n</fig>", "clean_text": " 5  PXRD patterns of simulated cp.1 (a, green), synthesized cp.1 (b, black), 5-Fu-loaded cp.1 (c, red), and 5-Fu (d, blue).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 37, "type": "text", "classification": ["property"], "content": "<p>TGA of synthesized <bold>cp.1</bold> was carried out to check the thermal stability of this novel coordination\npolymer (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">Figure S5</ext-link>). The curve shows three\nweight loss steps in which the first weight loss began at 24 \u00b0C\nand was completed at about 200 \u00b0C. This weight loss of 10.1%\nbelonged to the surface and subsequently clathrated water molecules.\nThe second and main weight loss of 33.2% was finished at 320 \u00b0C\nand might be attributed to the elimination of the organic part of\nthe molecule, such as unbounded 1,3,5-H<sub>3</sub>BTC ligand (calcd:\n34.9%). According to the curve, upon heating to 600 \u00b0C, two-step\nweight loss occurred, which could correspond to removing bonded 1,3,5-H<sub>3</sub>BTC molecules and continuous whole decomposition of the synthesized <bold>cp.1</bold>, which led to formation of unidentified product(s) above\n320 \u00b0C. The result suggests that the synthesized coordination\npolymer structure is thermally stable and applicable as a drug vehicle.</p>", "clean_text": "TGA of synthesized cp.1 was carried out to check the thermal stability of this novel coordination polymer (Figure S5). The curve shows three weight loss steps in which the first weight loss began at 24 \u00b0C and was completed at about 200 \u00b0C. This weight loss of 10.1% belonged to the surface and subsequently clathrated water molecules. The second and main weight loss of 33.2% was finished at 320 \u00b0C and might be attributed to the elimination of the organic part of the molecule, such as unbounded 1,3,5-H3BTC ligand (calcd: 34.9%). According to the curve, upon heating to 600 \u00b0C, two-step weight loss occurred, which could correspond to removing bonded 1,3,5-H3BTC molecules and continuous whole decomposition of the synthesized cp.1, which led to formation of unidentified product(s) above 320 \u00b0C. The result suggests that the synthesized coordination polymer structure is thermally stable and applicable as a drug vehicle.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 38, "type": "text", "classification": ["property"], "content": "<title>In Vitro 5-Fu Release Profile</title><p>The drug release experiment\nof 5-Fu-loaded <bold>cp.1</bold> was carried out at 37 \u00b0C in\n10% FBS as simulated human body fluid and was monitored via UV\u2013vis\nspectroscopy, which was performed in FBS 10% as analysis medium at\n\u03bb<sub>max</sub> = 296 nm (the calibration curve is displayed\nin <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">Figure S6</ext-link>). As shown in , the release rate has a great\nrelationship with the position of 5-Fu molecules between the chains\nof <bold>cp.1</bold> in which two kinds of interactions exist. The\nfirst 5-Fu release phase during initial 24 h (43.1%) belongs to the\n5-Fu\u20135-Fu intermolecular interactions, which are dominated\nbetween 5-Fu molecules that are away from the chain structure, and\neven to the considerably weak interactions between the 5-Fu and <bold>cp.1</bold>. The other forces are the undeniable host\u2013guest\ninteractions, which are the hydrogen bonds and \u03c0\u2013\u03c0\nstacking between 5-Fu molecules and <bold>cp.1</bold>. Therefore, the second phase of 5-Fu release\nduring the latter 48 h can correspond to these mentioned interactions.\nThus, with releasing 88.7% of the loaded drug, the 5-Fu release process\nwas completed in 72 h and it was associated with collapsing of <bold>cp.1</bold> crystalline structure, which is confirmed by PXRD pattern\nof <bold>cp.1</bold>. As observed in a, the crystalline structure of 5-Fu-loaded <bold>cp.1</bold> was totally ruined after 72 h and showed a noisy background\nin accordance with FBS PXRD pattern (b). Noteworthy, the 5-Fu release profile\nwas in good agreement with the other reported carriers.\n</p>", "clean_text": "In Vitro 5-Fu Release Profile\n\nThe drug release experiment of 5-Fu-loaded cp.1 was carried out at 37 \u00b0C in 10% FBS as simulated human body fluid and was monitored via UV-vis spectroscopy, which was performed in FBS 10% as analysis medium at \u03bbmax = 296 nm (the calibration curve is displayed in Figure S6). As shown in , the release rate has a great relationship with the position of 5-Fu molecules between the chains of cp.1 in which two kinds of interactions exist. The first 5-Fu release phase during initial 24 h (43.1%) belongs to the 5-Fu-5-Fu intermolecular interactions, which are dominated between 5-Fu molecules that are away from the chain structure, and even to the considerably weak interactions between the 5-Fu and cp.1. The other forces are the undeniable host-guest interactions, which are the hydrogen bonds and \u03c0-\u03c0 stacking between 5-Fu molecules and cp.1. Therefore, the second phase of 5-Fu release during the latter 48 h can correspond to these mentioned interactions. Thus, with releasing 88.7% of the loaded drug, the 5-Fu release process was completed in 72 h and it was associated with collapsing of cp.1 crystalline structure, which is confirmed by PXRD pattern of cp.1. As observed in a, the crystalline structure of 5-Fu-loaded cp.1 was totally ruined after 72 h and showed a noisy background in accordance with FBS PXRD pattern (b). Noteworthy, the 5-Fu release profile was in good agreement with the other reported carriers. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 39, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig6\" position=\"float\">\n<label>6</label>\n<caption>\n<p>5-Fu release\nfrom <bold>cp.1</bold> in 10% FBS at 37 \u00b0C.</p>\n</caption>\n<graphic id=\"gr7\" position=\"float\" xlink:href=\"am-2018-031116_0005.tif\"></graphic>\n</fig>", "clean_text": " 6  5-Fu release from cp.1 in 10% FBS at 37 \u00b0C.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 40, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig7\" position=\"float\">\n<label>7</label>\n<caption>\n<p>Powder XRD patterns of FBS (a) and 5-Fu-loaded <bold>cp.1</bold> after\n72 h release process in 10% FBS at 37 \u00b0C (b).</p>\n</caption>\n<graphic id=\"gr8\" position=\"float\" xlink:href=\"am-2018-031116_0006.tif\"></graphic>\n</fig>", "clean_text": " 7  Powder XRD patterns of FBS (a) and 5-Fu-loaded cp.1 after 72 h release process in 10% FBS at 37 \u00b0C (b).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 41, "type": "text", "classification": "error", "content": "<title>Cytotoxicity Assay</title><p>The cytotoxicity\neffect of synthesized <bold>cp.1</bold> as the blank carrier, 5-Fu-loaded <bold>cp.1</bold>, and 5-Fu as the free drug was examined against two breast\ncancer cell lines namely MCF-7 and 4T1 by MTT assay. All three formulas\nwere investigated at the 5-Fu concentration range of 0.01, 0.1, 0.5,\n1, 10, 50, and 100 \u03bcg/mL, and the nontreated cells served as\ncontrol. As depicted in a,b, the synthesized <bold>cp.1</bold> showed no cytotoxicity\non both cell lines, which revealed that the synthesized coordination\npolymer could be a potent biocompatible carrier. As previously reported, the expression and activity of thymidylate synthase and dihydropyrimidine\ndehydrogenase as two main factors in the molecular signaling pathway\nof chemoresistance to 5-Fu restrict the 5-Fu efficiency against the\ntumor cells. Moreover, it was observed in our experiments that the\nfree drug, 5-Fu, exhibited a notable drug resistance against both\ncell lines at 10 \u03bcg/mL, which is limiting the treatment process\nat all times, including 24, 48, and 72 h, whereas 5-Fu-loaded <bold>cp.1</bold> had a consistent 5-Fu release and consequently showed\neffective cytotoxicity on both MCF-7 and 4T1 cells with increasing\nconcentration during the treatment time.</p>", "clean_text": "Cytotoxicity Assay\n\nThe cytotoxicity effect of synthesized cp.1 as the blank carrier, 5-Fu-loaded cp.1, and 5-Fu as the free drug was examined against two breast cancer cell lines namely MCF-7 and 4T1 by MTT assay. All three formulas were investigated at the 5-Fu concentration range of 0.01, 0.1, 0.5, 1, 10, 50, and 100 \u03bcg/mL, and the nontreated cells served as control. As depicted in a,b, the synthesized cp.1 showed no cytotoxicity on both cell lines, which revealed that the synthesized coordination polymer could be a potent biocompatible carrier. As previously reported, the expression and activity of thymidylate synthase and dihydropyrimidine dehydrogenase as two main factors in the molecular signaling pathway of chemoresistance to 5-Fu restrict the 5-Fu efficiency against the tumor cells. Moreover, it was observed in our experiments that the free drug, 5-Fu, exhibited a notable drug resistance against both cell lines at 10 \u03bcg/mL, which is limiting the treatment process at all times, including 24, 48, and 72 h, whereas 5-Fu-loaded cp.1 had a consistent 5-Fu release and consequently showed effective cytotoxicity on both MCF-7 and 4T1 cells with increasing concentration during the treatment time.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 42, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig8\" position=\"float\">\n<label>8</label>\n<caption>\n<p>MTT assays of 5-Fu, 5-Fu-loaded <bold>cp.1</bold> as 5-Fu.<bold>cp.1</bold>, and <bold>cp.1</bold> in 24,\n48, and 72 h at the concentration range of 0 as control to 100 \u03bcg/mL\nagainst MCF-7 cells (a) and 4T1 cells (b). \u2605 indicates <italic>P</italic> &lt; 0.001 for 5-Fu vs 5-Fu.<bold>cp.1</bold> at the same\nconcentrations and same incubation times. Cell viability (%) comparison\nof 5-Fu.<bold>cp.1</bold> at different incubation times on MCF-7 cells\n(c) and 4T1 cells (d). The images of MCF-7 and 4T1 cells before and\nafter treatment with 5-Fu.<bold>cp.1</bold> (e) (asterisks show the\nstatistical significance).</p>\n</caption>\n<graphic id=\"gr9\" position=\"float\" xlink:href=\"am-2018-031116_0007.tif\"></graphic>\n</fig>", "clean_text": " 8  MTT assays of 5-Fu, 5-Fu-loaded cp.1 as 5-Fu.cp.1, and cp.1 in 24, 48, and 72 h at the concentration range of 0 as control to 100 \u03bcg/mL against MCF-7 cells (a) and 4T1 cells (b). \u2605 indicates P < 0.001 for 5-Fu vs 5-Fu.cp.1 at the same concentrations and same incubation times. Cell viability (%) comparison of 5-Fu.cp.1 at different incubation times on MCF-7 cells (c) and 4T1 cells (d). The images of MCF-7 and 4T1 cells before and after treatment with 5-Fu.cp.1 (e) (asterisks show the statistical significance).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 43, "type": "text", "classification": "error", "content": "<p>The IC<sub>50</sub> of free 5-Fu and 5-Fu-loaded <bold>cp.1</bold> against both MCF-7 and 4T1 cell lines was measured by the SigmaPlot\nsoftware at all examined incubation times of 24, 48, and 72 h. As\nshown in , after\n72 h, the inhibitory concentrations of 5-Fu-loaded <bold>cp.1</bold> and free 5-Fu were calculated to be 3.83 \u00b1 2.59, 0.38 \u00b1\n2.45 (MCF-7) and 1.54 \u00b1 2.72, 0.96 \u00b1 1.53 (4T1), respectively.\nThese results demonstrate that the 5-Fu sustained release process\nagainst MCF-7 cells occurred in a dose-dependent manner slightly more\neffectively than 4T1 cells. It may be due to the cell-associated particles,\nincluding the internalized and adhered ones, which can provide the\nadditional opportunities for the synthesized carrier to achieve greater\nintracellular drug levels.\n</p>", "clean_text": "The IC50 of free 5-Fu and 5-Fu-loaded cp.1 against both MCF-7 and 4T1 cell lines was measured by the SigmaPlot software at all examined incubation times of 24, 48, and 72 h. As shown in , after 72 h, the inhibitory concentrations of 5-Fu-loaded cp.1 and free 5-Fu were calculated to be 3.83 \u00b1 2.59, 0.38 \u00b1 2.45 (MCF-7) and 1.54 \u00b1 2.72, 0.96 \u00b1 1.53 (4T1), respectively. These results demonstrate that the 5-Fu sustained release process against MCF-7 cells occurred in a dose-dependent manner slightly more effectively than 4T1 cells. It may be due to the cell-associated particles, including the internalized and adhered ones, which can provide the additional opportunities for the synthesized carrier to achieve greater intracellular drug levels. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 44, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>IC<sub>50</sub> (\u03bcg/mL) Values of 5-Fu as Free Drug and 5-Fu-Loaded <bold>cp.1</bold> Against the Two Cell Lines MCF-7 and 4T1</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\"\u00b1\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\"\u00b1\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\"\u00b1\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\"\u00b1\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\" morerows=\"1\"></oasis:entry>\n<oasis:entry align=\"center\" nameend=\"col5\" namest=\"col2\" rowsep=\"1\">IC<sub>50</sub> (\u03bcg/mL)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry align=\"center\" nameend=\"col3\" namest=\"col2\" rowsep=\"1\">5-Fu</oasis:entry>\n<oasis:entry align=\"center\" nameend=\"col5\" namest=\"col4\" rowsep=\"1\">5-Fu.<bold>cp.1</bold>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry align=\"center\">incubation times (h)</oasis:entry>\n<oasis:entry align=\"center\">MCF-7</oasis:entry>\n<oasis:entry align=\"center\">4T1</oasis:entry>\n<oasis:entry align=\"center\">MCF-7</oasis:entry>\n<oasis:entry align=\"center\">4T1</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>24</oasis:entry>\n<oasis:entry>10.73\u00a0\u00b1\u00a02.21</oasis:entry>\n<oasis:entry>0.40\u00a0\u00b1\u00a01.72</oasis:entry>\n<oasis:entry>14.18\u00a0\u00b1\u00a03.21</oasis:entry>\n<oasis:entry>4.99\u00a0\u00b1\u00a01.09</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>48</oasis:entry>\n<oasis:entry>1.54\u00a0\u00b1\u00a00.77</oasis:entry>\n<oasis:entry>0.39\u00a0\u00b1\u00a01.23</oasis:entry>\n<oasis:entry>6.72\u00a0\u00b1\u00a01.03</oasis:entry>\n<oasis:entry>3.85\u00a0\u00b1\u00a02.01</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>72</oasis:entry>\n<oasis:entry>0.38\u00a0\u00b1\u00a02.45</oasis:entry>\n<oasis:entry>0.96\u00a0\u00b1\u00a01.53</oasis:entry>\n<oasis:entry>3.83\u00a0\u00b1\u00a02.59</oasis:entry>\n<oasis:entry>1.54\u00a0\u00b1\u00a02.72</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 45, "type": "text", "classification": ["else"], "content": "<p>According to the one-way ANOVA statistical analysis,\nthree groups were compared to each other. It should be noted that\nthe differences observed in control vs 5-Fu and control vs 5-Fu.<bold>cp.1</bold> groups were statistically significant (<italic>P</italic> &lt; 0.001) at all concentrations and all incubation times. The\nstatistically significant differences (<italic>P</italic> &lt; 0.001)\nin 5-Fu vs 5-Fu.<bold>cp.1</bold> groups are shown with asterisks\nin .</p>", "clean_text": "According to the one-way ANOVA statistical analysis, three groups were compared to each other. It should be noted that the differences observed in control vs 5-Fu and control vs 5-Fu.cp.1 groups were statistically significant (P < 0.001) at all concentrations and all incubation times. The statistically significant differences (P < 0.001) in 5-Fu vs 5-Fu.cp.1 groups are shown with asterisks in .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 46, "type": "text", "classification": ["else"], "content": "<title>Cellular\nUptake</title><p>The in vitro cellular uptake of <bold>cp.1</bold> and\nFITC-loaded <bold>cp.1</bold> in MCF-7 cells was studied by confocal\nimaging ().\nHere the BF, green, red, blue, and merge panels represent the bright\nfield, green filter to detect FITC-stained cells, red filter to detect\nstained lysosomes, blue filters to detect DAPI-stained nuclei of cells,\nand overlays of fluorescent images, respectively. As shown in a, the cellular uptake\nof <bold>cp.1</bold> particles was examined and the images revealed\nthat the synthesized particles have little emissions in green and\nred channels, which are saturated in overlaid image and detectable\nwith yellow filter. The results with bright fluorescence in b confirmed the presence\nof FITC-loaded <bold>cp.1</bold> particles in the MCF-7 cells, which\nproved the cellular uptake of 5-Fu-loaded <bold>cp.1</bold> in MCF-7\ncells. As it has been widely reported, the microparticle internalization\ninto cells is dependent on the size, shape, and surface charge that\npositively charged microparticles are preferentially taken up by cells. Therefore, the positive surface charge of synthesized <bold>cp.1</bold>s on one hand and its rodlike shape with high aspect ratio on the\nother can lead to the successful cellular uptake results. Moreover, to investigate the destination of internalized <bold>cp.1</bold>s, LysoTracker Red probes were applied to detect lysosomes. The colocalization\nof <bold>cp.1</bold>s with lysosomes was observed in c. The images confirmed the\nefficient cellular uptake of <bold>cp.1</bold>s through endocytosis\nmechanism.</p>", "clean_text": "Cellular Uptake\n\nThe in vitro cellular uptake of cp.1 and FITC-loaded cp.1 in MCF-7 cells was studied by confocal imaging (). Here the BF, green, red, blue, and merge panels represent the bright field, green filter to detect FITC-stained cells, red filter to detect stained lysosomes, blue filters to detect DAPI-stained nuclei of cells, and overlays of fluorescent images, respectively. As shown in a, the cellular uptake of cp.1 particles was examined and the images revealed that the synthesized particles have little emissions in green and red channels, which are saturated in overlaid image and detectable with yellow filter. The results with bright fluorescence in b confirmed the presence of FITC-loaded cp.1 particles in the MCF-7 cells, which proved the cellular uptake of 5-Fu-loaded cp.1 in MCF-7 cells. As it has been widely reported, the microparticle internalization into cells is dependent on the size, shape, and surface charge that positively charged microparticles are preferentially taken up by cells. Therefore, the positive surface charge of synthesized cp.1s on one hand and its rodlike shape with high aspect ratio on the other can lead to the successful cellular uptake results. Moreover, to investigate the destination of internalized cp.1s, LysoTracker Red probes were applied to detect lysosomes. The colocalization of cp.1s with lysosomes was observed in c. The images confirmed the efficient cellular uptake of cp.1s through endocytosis mechanism.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 47, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig9\" position=\"float\">\n<label>9</label>\n<caption>\n<p>Confocal images of MCF-7 cells after being incubated with <bold>cp.1</bold> as blank (a), FITC-loaded <bold>cp.1</bold> (b), and\nLysoTracker Red for lysosome detection (c). From the left side, BF\nis the bright-field images of the cells. Green, red, and blue panels\nare dedicated to the fluorescent images, which are filtered by the\ngreen, red, and blue filters in CLSM. Merge is the overlays of fluorescent\nimages in each incubations. Scale bars: 100 \u03bcm.</p>\n</caption>\n<graphic id=\"gr10\" position=\"float\" xlink:href=\"am-2018-031116_0008.tif\"></graphic>\n</fig>", "clean_text": " 9  Confocal images of MCF-7 cells after being incubated with cp.1 as blank (a), FITC-loaded cp.1 (b), and LysoTracker Red for lysosome detection (c). From the left side, BF is the bright-field images of the cells. Green, red, and blue panels are dedicated to the fluorescent images, which are filtered by the green, red, and blue filters in CLSM. Merge is the overlays of fluorescent images in each incubations. Scale bars: 100 \u03bcm.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 48, "type": "text", "classification": "error", "content": "<title>In Vivo Antitumor Activity of 5-Fu-Loaded <bold>cp.1</bold>s</title><p>The in vivo antitumor efficacy of the 5-Fu-loaded <bold>cp.1</bold> particles was evaluated on the 4T1 female BALB/c tumor\nmodel. In our study, intratumoral (it)\ninjections of 5-Fu as free drug and 5-Fu-loaded <bold>cp.1</bold>s\nwere chosen as the locoregional treatment. The treatment was performed\non day 0 in a single dose (11 mg/kg), and the tumor size was followed\nevery 3 days during the 28 days. The untreated group was set as control.\nAs displayed in , the speed of tumor growth was in the same manner during\n9 days after treatment in both 5-Fu and 5-Fu.<bold>cp.1</bold> groups.\nDuring the next 20 days, the tumor growth in 5-Fu.<bold>cp.1</bold> group slowed down because of the sustained release of 5-Fu from <bold>cp.1</bold> compared to the 5-Fu group, which may be because of the\nchosen low dose in the experiment. On\nday 28, the mice were sacrificed and the mean tumor volumes were measured\nas 2463.35 for 5-Fu group and 1900.11 for 5-Fu.<bold>cp.1</bold> group.\nOne-way ANOVA statistical analysis revealed that the tumor sizes in\nthe 5-Fu.<bold>cp.1</bold> group were significantly smaller (<italic>P</italic> &lt; 0.05) than those in the 5-Fu group.</p>", "clean_text": "In Vivo Antitumor Activity of 5-Fu-Loaded cp.1s\n\nThe in vivo antitumor efficacy of the 5-Fu-loaded cp.1 particles was evaluated on the 4T1 female BALB/c tumor model. In our study, intratumoral (it) injections of 5-Fu as free drug and 5-Fu-loaded cp.1s were chosen as the locoregional treatment. The treatment was performed on day 0 in a single dose (11 mg/kg), and the tumor size was followed every 3 days during the 28 days. The untreated group was set as control. As displayed in , the speed of tumor growth was in the same manner during 9 days after treatment in both 5-Fu and 5-Fu.cp.1 groups. During the next 20 days, the tumor growth in 5-Fu.cp.1 group slowed down because of the sustained release of 5-Fu from cp.1 compared to the 5-Fu group, which may be because of the chosen low dose in the experiment. On day 28, the mice were sacrificed and the mean tumor volumes were measured as 2463.35 for 5-Fu group and 1900.11 for 5-Fu.cp.1 group. One-way ANOVA statistical analysis revealed that the tumor sizes in the 5-Fu.cp.1 group were significantly smaller (P < 0.05) than those in the 5-Fu group.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 49, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig10\" position=\"float\">\n<label>10</label>\n<caption>\n<p>(a) Effect of intratumoral\napplication of 5-Fu-loaded <bold>cp.1</bold> (red) and 5-Fu (blue)\non the growth of mammary adenocarcinoma 4T1 transplanted subcutaneously\ninto BALB/c mouse mammary glands. 5-Fu-loaded <bold>cp.1</bold> and\n5-Fu were injected with a dose of 11 mg/kg once on day 0 (10 days\nafter tumor transplantation). \u2033Black diamond minus white X\u2033\nindicates <italic>P</italic> &lt; 0.05 significant differences between\neach treatment and control. \u2033Double black diamond minus white\nX\u2033 indicates <italic>P</italic> &lt; 0.05 significant differences\nbetween 5-Fu-loaded <bold>cp.1</bold> and 5-Fu treatments on a particular\nday. Each experimental group consisted of five animals. (b) Photographs\nof stripped tumor tissues and (c) female BALB/c mice bearing breast\ncancer.</p>\n</caption>\n<graphic id=\"gr11\" position=\"float\" xlink:href=\"am-2018-031116_0009.tif\"></graphic>\n</fig>", "clean_text": " 10  (a) Effect of intratumoral application of 5-Fu-loaded cp.1 (red) and 5-Fu (blue) on the growth of mammary adenocarcinoma 4T1 transplanted subcutaneously into BALB/c mouse mammary glands. 5-Fu-loaded cp.1 and 5-Fu were injected with a dose of 11 mg/kg once on day 0 (10 days after tumor transplantation). \"Black diamond minus white X\" indicates P < 0.05 significant differences between each treatment and control. \"Double black diamond minus white X\" indicates P < 0.05 significant differences between 5-Fu-loaded cp.1 and 5-Fu treatments on a particular day. Each experimental group consisted of five animals. (b) Photographs of stripped tumor tissues and (c) female BALB/c mice bearing breast cancer.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 50, "type": "text", "classification": "error", "content": "<title>Histopathological Study</title><p>Tumor sections from different treatment groups were graded histologically\nusing the Nottingham histologic grading system. The results are shown\nin . Many\ndisproportionate tumor cells (anisocytosis), nuclear polymorphism\n(anisokaryosis, +3), and prominent nucleoli were seen in untreated\nanimals (control). Glandular (acinar/tubular) differentiation (GF)\nis low (+3), and the mitotic index in 10 HPF (400\u00d7) is +3. Overall,\nthe tumors in these groups were considered as grade 3 (poorly differentiated).\nIn free drug (5-Fu) group, mitotic index was lower than that of the\ncontrol group (+2). In this group, the GF was low (+2) and nuclear\npolymorphism and the anisocytosis were decreased in comparison with\nthe control group (+2). Moreover, some apoptotic tumor cells and necrosis\n(asterisks) were seen in this group. Grade 2 (moderately differentiated)\nwas considered for the tumor sections in free drug group. In the group\ntreated with 5-Fu-loaded <bold>cp.1</bold> (named as particle drug),\nnuclear polymorphism (+1), GF (+2), and the mitotic index in 10 HPF\n(+1) of tumor tissue sections were decreased in comparison to the\nother groups. Furthermore, massive necrosis of breast cancer cells\nwas seen in these groups. The histopathological findings and scoring\nsystem showed a considerable difference between particle drug-treated\nanimals and the other groups. Several inflammatory cells had also\ninfiltrated into necrotic areas. The tumor in this group was considered\nas grade 1 breast cancer (well differentiated).</p>", "clean_text": "Histopathological Study\n\nTumor sections from different treatment groups were graded histologically using the Nottingham histologic grading system. The results are shown in . Many disproportionate tumor cells (anisocytosis), nuclear polymorphism (anisokaryosis, +3), and prominent nucleoli were seen in untreated animals (control). Glandular (acinar/tubular) differentiation (GF) is low (+3), and the mitotic index in 10 HPF (400\u00d7) is +3. Overall, the tumors in these groups were considered as grade 3 (poorly differentiated). In free drug (5-Fu) group, mitotic index was lower than that of the control group (+2). In this group, the GF was low (+2) and nuclear polymorphism and the anisocytosis were decreased in comparison with the control group (+2). Moreover, some apoptotic tumor cells and necrosis (asterisks) were seen in this group. Grade 2 (moderately differentiated) was considered for the tumor sections in free drug group. In the group treated with 5-Fu-loaded cp.1 (named as particle drug), nuclear polymorphism (+1), GF (+2), and the mitotic index in 10 HPF (+1) of tumor tissue sections were decreased in comparison to the other groups. Furthermore, massive necrosis of breast cancer cells was seen in these groups. The histopathological findings and scoring system showed a considerable difference between particle drug-treated animals and the other groups. Several inflammatory cells had also infiltrated into necrotic areas. The tumor in this group was considered as grade 1 breast cancer (well differentiated).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 51, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig11\" position=\"float\">\n<label>11</label>\n<caption>\n<p>Histopathology of breast\ncancer in different groups. Thick arrows: mitotic figures; asterisks\n(*): necrosis area; thin arrows: infiltration of inflammatory cells.\nH&amp;E stain.</p>\n</caption>\n<graphic id=\"gr12\" position=\"float\" xlink:href=\"am-2018-031116_0010.tif\"></graphic>\n</fig>", "clean_text": " 11  Histopathology of breast cancer in different groups. Thick arrows: mitotic figures; asterisks (*): necrosis area; thin arrows: infiltration of inflammatory cells. H&E stain.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 52, "type": "text", "classification": "error", "content": "<title>Conclusions</title><p>Herein,\nwe synthesized a novel 1D coordination polymer, <bold>cp.1</bold>,\nby one-pot hydrothermal method. The synthesized <bold>cp.1</bold> was\napplied as a biocompatible microcarrier for anticancer drug delivery\npurposes. Therefore, we used 5-Fu, a small and widely used anticancer\nagent against breast cancer. Interestingly, we achieved 66% drug loading\nwith 98% encapsulation efficiency, which may be due to the effective\ninteractions, such as \u03c0\u2013\u03c0 stacking and H-bonding\nbetween 5-Fu molecule and <bold>cp.1</bold>. The release process was\ncarried out in 10% FBS as a simulated body fluid, and the <bold>cp.1</bold> showed an almost complete release profile associated with collapsing\nthe network. In vitro cytotoxicity effects of the synthesized <bold>cp.1</bold>, 5-Fu, and 5-Fu-loaded <bold>cp.1</bold> were examined\nagainst human and mouse breast cancer cell lines MCF-7 and 4T1. The\nresults indicated that the synthesized <bold>cp.1</bold> had no significant\ncytotoxic effect on either of the cell lines. Also, the 5-Fu-loaded <bold>cp.1</bold> showed a time-dependent 5-Fu release, which is confirmed\nby the effectiveness of 5-Fu-loaded <bold>cp.1</bold> against cancer\ncells. CLSM images revealed that the synthesized <bold>cp.1</bold> had a significant cellular uptake. In vivo study affirmed the effective\nantitumoral activity of 5-Fu-loaded <bold>cp.1</bold>, which was intratumorally\nadministrated in 4T1 tumor BALB/c mouse model. Thus, this study introduced\na novel anticancer drug delivery vehicle for locoregional breast cancer\nchemotherapy and its possibility for further clinical application.</p>", "clean_text": "Conclusions\n\nHerein, we synthesized a novel 1D coordination polymer, cp.1, by one-pot hydrothermal method. The synthesized cp.1 was applied as a biocompatible microcarrier for anticancer drug delivery purposes. Therefore, we used 5-Fu, a small and widely used anticancer agent against breast cancer. Interestingly, we achieved 66% drug loading with 98% encapsulation efficiency, which may be due to the effective interactions, such as \u03c0-\u03c0 stacking and H-bonding between 5-Fu molecule and cp.1. The release process was carried out in 10% FBS as a simulated body fluid, and the cp.1 showed an almost complete release profile associated with collapsing the network. In vitro cytotoxicity effects of the synthesized cp.1, 5-Fu, and 5-Fu-loaded cp.1 were examined against human and mouse breast cancer cell lines MCF-7 and 4T1. The results indicated that the synthesized cp.1 had no significant cytotoxic effect on either of the cell lines. Also, the 5-Fu-loaded cp.1 showed a time-dependent 5-Fu release, which is confirmed by the effectiveness of 5-Fu-loaded cp.1 against cancer cells. CLSM images revealed that the synthesized cp.1 had a significant cellular uptake. In vivo study affirmed the effective antitumoral activity of 5-Fu-loaded cp.1, which was intratumorally administrated in 4T1 tumor BALB/c mouse model. Thus, this study introduced a novel anticancer drug delivery vehicle for locoregional breast cancer chemotherapy and its possibility for further clinical application.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 53, "type": "text", "classification": ["else"], "content": "<p>The Supporting\nInformation is available free of charge on the <ext-link xlink:href=\"http://pubs.acs.org\">ACS Publications website</ext-link> at\nDOI: <ext-link xlink:href=\"http://pubs.acs.org/doi/abs/10.1021/acsami.8b03111\">10.1021/acsami.8b03111</ext-link>.<list id=\"silist\" list-type=\"label\">\n<list-item>\n<p>View of the asymmetric unit, noncovalent interactions\nof <bold>cp.1</bold>, UV\u2013visible spectra, \u03b6-potentials,\nTGA profile (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">PDF</ext-link>)</p>\n</list-item>\n<list-item>\n<p>Crystallographic data (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_002.cif\">CIF</ext-link>)</p>\n</list-item>\n</list>\n</p>", "clean_text": "The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acsami.8b03111.  View of the asymmetric unit, noncovalent interactions of cp.1, UV-visible spectra, \u03b6-potentials, TGA profile (PDF)   Crystallographic data (CIF)   ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 54, "type": "text", "classification": ["else"], "content": "<p>View of the asymmetric unit, noncovalent interactions\nof <bold>cp.1</bold>, UV\u2013visible spectra, \u03b6-potentials,\nTGA profile (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">PDF</ext-link>)</p><p>Crystallographic data (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_002.cif\">CIF</ext-link>)</p><p>The authors declare no competing\nfinancial interest.</p><title>Abbreviations</title><p>coordination polymer <bold>1</bold>\n</p><p>5-fluorouracil</p><p>3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium\nbromide</p><p>1,3,5-benzenetricarboxylic acid</p><p>fetal bovine serum</p>", "clean_text": "View of the asymmetric unit, noncovalent interactions of cp.1, UV-visible spectra, \u03b6-potentials, TGA profile (PDF)\n\nCrystallographic data (CIF)\n\nThe authors declare no competing financial interest.\n\nAbbreviations\n\ncoordination polymer 1 \n\n5-fluorouracil\n\n3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\n\n1,3,5-benzenetricarboxylic acid\n\nfetal bovine serum", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": 11, "type": "text", "classification": "synthesis condition", "content": "<title>Synthesis of Compound [Zn\u00ad(H<sub>2</sub>O)<sub>6</sub>K<sub>2</sub>(H<sub>2</sub>BTC)<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>]\u00ad(H<sub>2</sub>BTC)<sub>2</sub>\u00b72H<sub>2</sub>O <bold>(cp.1)</bold>\n</title><p>A mixture of Zn\u00ad(NO<sub>3</sub>)<sub>2</sub>\u00b76H<sub>2</sub>O (0.1 mmol), H<sub>3</sub>BTC (0.3 mmol), KOH (0.5 mmol), and H<sub>2</sub>O (5 mL) was placed in a Teflon-lined autoclave. It was held\nat 200 \u00b0C for 3 days with cooling ramp of 96 h. In the purification\nstep, the colorless needle crystals were centrifuged, washed with\nfresh distilled water three times, and then dried at room temperature.</p>", "clean_text": "Synthesis of Compound [Zn(H2O)6K2(H2BTC)2(H2O)4](H2BTC)2\u22c52H2O (cp.1) \n\nA mixture of Zn(NO3)2\u22c56H2O (0.1 mmol), H3BTC (0.3 mmol), KOH (0.5 mmol), and H2O (5 mL) was placed in a Teflon-lined autoclave. It was held at 200 \u00b0C for 3 days with cooling ramp of 96 h. In the purification step, the colorless needle crystals were centrifuged, washed with fresh distilled water three times, and then dried at room temperature.", "data": [[{"meta": {"name": "[Zn(H2O)6K2(H2BTC)2(H2O)4](H2BTC)2\u22c52H2O", "symbol": "cp.1", "chemical formula": ""}, "processes": [{"synthesis method": "solvothermal synthesis", "precursor": [{"name": "Zn(NO3)2\u22c56H2O", "amount": "0.1", "unit": "mmol"}, {"name": "H3BTC", "amount": "0.3", "unit": "mmol"}, {"name": "KOH", "amount": "0.5", "unit": "mmol"}], "solvent": [{"name": "H2O", "amount": "5", "unit": "mL"}], "reducing agent": [{"name": "", "amount": "", "unit": ""}], "surfactant": [{"name": "", "amount": "", "unit": ""}], "pressure": "", "temperature": "200\u00b0C", "time": "3 days", "heating rate": "", "cooling rate": "96 h"}, {"synthesis method": "centrifugation", "revolution per time": "", "relative centrifugal force": "", "time": "", "temperature": "", "additive": [{"name": "", "amount": "", "unit": ""}], "tube material": "", "tube volume": ""}, {"synthesis method": "washing", "washing solution": "fresh distilled water", "amount": "three times"}, {"synthesis method": "drying", "pressure": "", "temperature": "room temperature", "atmosphere": "", "time": ""}], "yield": ""}]], "include_properties": ["washing", "solvothermal_synthesis", "drying", "centrifugation"], "intermediate_step": {"text-synthesis-type": "['solvothermal_synthesis', 'centrifugation', 'washing', 'drying']", "text-synthesis-struct": "```JSON\n[{\"meta\":{\"name\":\"[Zn(H2O)6K2(H2BTC)2(H2O)4](H2BTC)2\u22c52H2O\", \"symbol\":\"cp.1\", \"chemical formula\":\"\"}, \"processes\":[{\"synthesis method\": \"solvothermal synthesis\", \"precursor\":[{\"name\":\"Zn(NO3)2\u22c56H2O\", \"amount\":\"0.1\", \"unit\":\"mmol\"}, {\"name\":\"H3BTC\", \"amount\":\"0.3\", \"unit\":\"mmol\"}, {\"name\":\"KOH\", \"amount\":\"0.5\", \"unit\":\"mmol\"}], \"solvent\":[{\"name\":\"H2O\", \"amount\":\"5\", \"unit\":\"mL\"}], \"reducing agent\":[{\"name\":\"\", \"amount\":\"\", \"unit\":\"\"}], \"surfactant\":[{\"name\":\"\", \"amount\":\"\", \"unit\":\"\"}], \"pressure\":\"\", \"temperature\":\"200\u00b0C\", \"time\":\"3 days\", \"heating rate\":\"\", \"cooling rate\":\"96 h\"}, {\"synthesis method\":\"centrifugation\", \"revolution per time\":\"\", \"relative centrifugal force\":\"\", \"time\":\"\", \"temperature\":\"\", \"additive\":[{\"name\":\"\", \"amount\":\"\", \"unit\":\"\"}], \"tube material\":\"\", \"tube volume\":\"\"}, {\"synthesis method\":\"washing\", \"washing solution\":\"fresh distilled water\", \"amount\":\"three times\"}, {\"synthesis method\":\"drying\", \"pressure\":\"\", \"temperature\":\"room temperature\", \"atmosphere\":\"\", \"time\":\"\"}], \"yield\":\"\"}]\n```"}}, {"idx": "26, 37, 38", "type": "text", "classification": "property", "content": "<title>5-Fu Loading Process</title><p>5-Fluorouracil\n(5.3 \u00d7 5.0 \u00c5<sup>2</sup>) is a small and widely used anticancer\ndrug, which is applied for treatment of various cancer tumors. The\nloading process with 1:2 ratio of <bold>cp.1</bold>/5-Fu was examined\nin distilled water. The drug loading (DL) and encapsulation efficiency\n(EE) were investigated by UV\u2013vis spectroscopy with the correlation\ncoefficient of <italic>R</italic>\n<sup>2</sup> = 0.999, which were\nobtained as 66.27 \u00b1 2.1 and 98.26 wt %, respectively. The adsorption\nof 5-Fu on the chains of <bold>cp.1</bold> leads to an obvious decrease\nin adsorption intensity (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">Figure S3</ext-link>). This outstanding amount of loading\nmight be due to the small size of 5-Fu molecules and more importantly\nthe existence of host\u2013guest interactions, such as H-bonding\n(between amine groups of 5-Fu and COOH groups of <bold>cp.1</bold>) and \u03c0\u2013\u03c0 stacking between 5-Fu molecule and <bold>cp.1.</bold>\n\n</p><p>TGA of synthesized <bold>cp.1</bold> was carried out to check the thermal stability of this novel coordination\npolymer (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">Figure S5</ext-link>). The curve shows three\nweight loss steps in which the first weight loss began at 24 \u00b0C\nand was completed at about 200 \u00b0C. This weight loss of 10.1%\nbelonged to the surface and subsequently clathrated water molecules.\nThe second and main weight loss of 33.2% was finished at 320 \u00b0C\nand might be attributed to the elimination of the organic part of\nthe molecule, such as unbounded 1,3,5-H<sub>3</sub>BTC ligand (calcd:\n34.9%). According to the curve, upon heating to 600 \u00b0C, two-step\nweight loss occurred, which could correspond to removing bonded 1,3,5-H<sub>3</sub>BTC molecules and continuous whole decomposition of the synthesized <bold>cp.1</bold>, which led to formation of unidentified product(s) above\n320 \u00b0C. The result suggests that the synthesized coordination\npolymer structure is thermally stable and applicable as a drug vehicle.</p><title>In Vitro 5-Fu Release Profile</title><p>The drug release experiment\nof 5-Fu-loaded <bold>cp.1</bold> was carried out at 37 \u00b0C in\n10% FBS as simulated human body fluid and was monitored via UV\u2013vis\nspectroscopy, which was performed in FBS 10% as analysis medium at\n\u03bb<sub>max</sub> = 296 nm (the calibration curve is displayed\nin <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.8b03111/suppl_file/am8b03111_si_001.pdf\">Figure S6</ext-link>). As shown in , the release rate has a great\nrelationship with the position of 5-Fu molecules between the chains\nof <bold>cp.1</bold> in which two kinds of interactions exist. The\nfirst 5-Fu release phase during initial 24 h (43.1%) belongs to the\n5-Fu\u20135-Fu intermolecular interactions, which are dominated\nbetween 5-Fu molecules that are away from the chain structure, and\neven to the considerably weak interactions between the 5-Fu and <bold>cp.1</bold>. The other forces are the undeniable host\u2013guest\ninteractions, which are the hydrogen bonds and \u03c0\u2013\u03c0\nstacking between 5-Fu molecules and <bold>cp.1</bold>. Therefore, the second phase of 5-Fu release\nduring the latter 48 h can correspond to these mentioned interactions.\nThus, with releasing 88.7% of the loaded drug, the 5-Fu release process\nwas completed in 72 h and it was associated with collapsing of <bold>cp.1</bold> crystalline structure, which is confirmed by PXRD pattern\nof <bold>cp.1</bold>. As observed in a, the crystalline structure of 5-Fu-loaded <bold>cp.1</bold> was totally ruined after 72 h and showed a noisy background\nin accordance with FBS PXRD pattern (b). Noteworthy, the 5-Fu release profile\nwas in good agreement with the other reported carriers.\n</p>", "clean_text": "5-Fu Loading Process\n\n5-Fluorouracil (5.3 \u00d7 5.0 \u00c52) is a small and widely used anticancer drug, which is applied for treatment of various cancer tumors. The loading process with 1:2 ratio of cp.1/5-Fu was examined in distilled water. The drug loading (DL) and encapsulation efficiency (EE) were investigated by UV-vis spectroscopy with the correlation coefficient of R 2 = 0.999, which were obtained as 66.27 \u00b1 2.1 and 98.26 wt %, respectively. The adsorption of 5-Fu on the chains of cp.1 leads to an obvious decrease in adsorption intensity (Figure S3). This outstanding amount of loading might be due to the small size of 5-Fu molecules and more importantly the existence of host-guest interactions, such as H-bonding (between amine groups of 5-Fu and COOH groups of cp.1) and \u03c0-\u03c0 stacking between 5-Fu molecule and cp.1.  \n\nTGA of synthesized cp.1 was carried out to check the thermal stability of this novel coordination polymer (Figure S5). The curve shows three weight loss steps in which the first weight loss began at 24 \u00b0C and was completed at about 200 \u00b0C. This weight loss of 10.1% belonged to the surface and subsequently clathrated water molecules. The second and main weight loss of 33.2% was finished at 320 \u00b0C and might be attributed to the elimination of the organic part of the molecule, such as unbounded 1,3,5-H3BTC ligand (calcd: 34.9%). According to the curve, upon heating to 600 \u00b0C, two-step weight loss occurred, which could correspond to removing bonded 1,3,5-H3BTC molecules and continuous whole decomposition of the synthesized cp.1, which led to formation of unidentified product(s) above 320 \u00b0C. The result suggests that the synthesized coordination polymer structure is thermally stable and applicable as a drug vehicle.\n\nIn Vitro 5-Fu Release Profile\n\nThe drug release experiment of 5-Fu-loaded cp.1 was carried out at 37 \u00b0C in 10% FBS as simulated human body fluid and was monitored via UV-vis spectroscopy, which was performed in FBS 10% as analysis medium at \u03bbmax = 296 nm (the calibration curve is displayed in Figure S6). As shown in , the release rate has a great relationship with the position of 5-Fu molecules between the chains of cp.1 in which two kinds of interactions exist. The first 5-Fu release phase during initial 24 h (43.1%) belongs to the 5-Fu-5-Fu intermolecular interactions, which are dominated between 5-Fu molecules that are away from the chain structure, and even to the considerably weak interactions between the 5-Fu and cp.1. The other forces are the undeniable host-guest interactions, which are the hydrogen bonds and \u03c0-\u03c0 stacking between 5-Fu molecules and cp.1. Therefore, the second phase of 5-Fu release during the latter 48 h can correspond to these mentioned interactions. Thus, with releasing 88.7% of the loaded drug, the 5-Fu release process was completed in 72 h and it was associated with collapsing of cp.1 crystalline structure, which is confirmed by PXRD pattern of cp.1. As observed in a, the crystalline structure of 5-Fu-loaded cp.1 was totally ruined after 72 h and showed a noisy background in accordance with FBS PXRD pattern (b). Noteworthy, the 5-Fu release profile was in good agreement with the other reported carriers. ", "data": [[[{"meta": {"name": "5-Fluorouracil", "symbol": "5-Fu", "chemical formula": "C4H3FN2O2"}, "etc": [{"property name": "drug loading", "value": "66.27 \u00b1 2.1", "unit": "wt %", "condition": ""}, {"property name": "encapsulation efficiency", "value": "98.26", "unit": "wt %", "condition": ""}], "decomposition temperature": [{"value": "24 to 200", "unit": "\u00b0C", "type": "surface and clathrated water molecules", "condition": ""}, {"value": "320", "unit": "\u00b0C", "type": "elimination of the organic part", "condition": ""}, {"value": "600", "unit": "\u00b0C", "type": "removing bonded 1,3,5-H3BTC molecules and continuous whole decomposition", "condition": ""}]}]]], "include_properties": ["etc", "decomposition_temperature"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['etc', 'decomposition_temperature']", "text-property-extract": "```JSON\n[{\"meta\":{\"name\":\"5-Fluorouracil\", \"symbol\":\"5-Fu\", \"chemical formula\":\"C4H3FN2O2\"},\n\"etc\": [\n    {\"property name\": \"drug loading\", \"value\":\"66.27 \u00b1 2.1\", \"unit\":\"wt %\", \"condition\":\"\"},\n    {\"property name\": \"encapsulation efficiency\", \"value\":\"98.26\", \"unit\":\"wt %\", \"condition\":\"\"}\n],\n\"decomposition temperature\": [\n    {\"value\":\"24 to 200\", \"unit\":\"\u00b0C\", \"type\":\"surface and clathrated water molecules\", \"condition\":\"\"},\n    {\"value\":\"320\", \"unit\":\"\u00b0C\", \"type\":\"elimination of the organic part\", \"condition\":\"\"},\n    {\"value\":\"600\", \"unit\":\"\u00b0C\", \"type\":\"removing bonded 1,3,5-H3BTC molecules and continuous whole decomposition\", \"condition\":\"\"}\n]}]\n```"}}, {"idx": 44, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>IC<sub>50</sub> (\u03bcg/mL) Values of 5-Fu as Free Drug and 5-Fu-Loaded <bold>cp.1</bold> Against the Two Cell Lines MCF-7 and 4T1</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\"\u00b1\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\"\u00b1\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\"\u00b1\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\"\u00b1\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\" morerows=\"1\"></oasis:entry>\n<oasis:entry align=\"center\" nameend=\"col5\" namest=\"col2\" rowsep=\"1\">IC<sub>50</sub> (\u03bcg/mL)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry align=\"center\" nameend=\"col3\" namest=\"col2\" rowsep=\"1\">5-Fu</oasis:entry>\n<oasis:entry align=\"center\" nameend=\"col5\" namest=\"col4\" rowsep=\"1\">5-Fu.<bold>cp.1</bold>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry align=\"center\">incubation times (h)</oasis:entry>\n<oasis:entry align=\"center\">MCF-7</oasis:entry>\n<oasis:entry align=\"center\">4T1</oasis:entry>\n<oasis:entry align=\"center\">MCF-7</oasis:entry>\n<oasis:entry align=\"center\">4T1</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>24</oasis:entry>\n<oasis:entry>10.73\u00a0\u00b1\u00a02.21</oasis:entry>\n<oasis:entry>0.40\u00a0\u00b1\u00a01.72</oasis:entry>\n<oasis:entry>14.18\u00a0\u00b1\u00a03.21</oasis:entry>\n<oasis:entry>4.99\u00a0\u00b1\u00a01.09</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>48</oasis:entry>\n<oasis:entry>1.54\u00a0\u00b1\u00a00.77</oasis:entry>\n<oasis:entry>0.39\u00a0\u00b1\u00a01.23</oasis:entry>\n<oasis:entry>6.72\u00a0\u00b1\u00a01.03</oasis:entry>\n<oasis:entry>3.85\u00a0\u00b1\u00a02.01</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>72</oasis:entry>\n<oasis:entry>0.38\u00a0\u00b1\u00a02.45</oasis:entry>\n<oasis:entry>0.96\u00a0\u00b1\u00a01.53</oasis:entry>\n<oasis:entry>3.83\u00a0\u00b1\u00a02.59</oasis:entry>\n<oasis:entry>1.54\u00a0\u00b1\u00a02.72</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 1. IC<sub>50</sub> (\u03bcg/mL) Values of 5-Fu as Free Drug and 5-Fu-Loaded cp.1 Against the Two Cell Lines MCF-7 and 4T1\n\n|           | IC<sub>50</sub> (\u03bcg/mL) |      |      |      |\n|           | 5-Fu                    | 5-Fu.cp.1 |      |      |\n|           | incubation times (h)   | MCF-7    | 4T1  | MCF-7 | 4T1  |\n| 24        | 10.73\u00a0\u00b1\u00a02.21            | 0.40\u00a0\u00b1\u00a01.72 | 14.18\u00a0\u00b1\u00a03.21 | 4.99\u00a0\u00b1\u00a01.09 |\n| 48        | 1.54\u00a0\u00b1\u00a00.77             | 0.39\u00a0\u00b1\u00a01.23 | 6.72\u00a0\u00b1\u00a01.03  | 3.85\u00a0\u00b1\u00a02.01 |\n| 72        | 0.38\u00a0\u00b1\u00a02.45             | 0.96\u00a0\u00b1\u00a01.53 | 3.83\u00a0\u00b1\u00a02.59  | 1.54\u00a0\u00b1\u00a02.72 |", "data": [[{"meta": {"name": "5-Fu", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC<sub>50</sub>", "value": "10.73 \u00b1 2.21", "unit": "\u03bcg/mL", "condition": "24h incubation, MCF-7 cell line"}, {"property name": "IC<sub>50</sub>", "value": "1.54 \u00b1 0.77", "unit": "\u03bcg/mL", "condition": "48h incubation, MCF-7 cell line"}, {"property name": "IC<sub>50</sub>", "value": "0.38 \u00b1 2.45", "unit": "\u03bcg/mL", "condition": "72h incubation, MCF-7 cell line"}]}, {"meta": {"name": "5-Fu.cp.1", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC<sub>50</sub>", "value": "0.40 \u00b1 1.72", "unit": "\u03bcg/mL", "condition": "24h incubation, MCF-7 cell line"}, {"property name": "IC<sub>50</sub>", "value": "0.39 \u00b1 1.23", "unit": "\u03bcg/mL", "condition": "48h incubation, MCF-7 cell line"}, {"property name": "IC<sub>50</sub>", "value": "0.96 \u00b1 1.53", "unit": "\u03bcg/mL", "condition": "72h incubation, MCF-7 cell line"}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. IC<sub>50</sub> (\u03bcg/mL) Values of 5-Fu as Free Drug and 5-Fu-Loaded cp.1 Against the Two Cell Lines MCF-7 and 4T1\n\n|           | IC<sub>50</sub> (\u03bcg/mL) |      |      |      |\n|           | 5-Fu                    | 5-Fu.cp.1 |      |      |\n|           | incubation times (h)   | MCF-7    | 4T1  | MCF-7 | 4T1  |\n| 24        | 10.73\u00a0\u00b1\u00a02.21            | 0.40\u00a0\u00b1\u00a01.72 | 14.18\u00a0\u00b1\u00a03.21 | 4.99\u00a0\u00b1\u00a01.09 |\n| 48        | 1.54\u00a0\u00b1\u00a00.77             | 0.39\u00a0\u00b1\u00a01.23 | 6.72\u00a0\u00b1\u00a01.03  | 3.85\u00a0\u00b1\u00a02.01 |\n| 72        | 0.38\u00a0\u00b1\u00a02.45             | 0.96\u00a0\u00b1\u00a01.53 | 3.83\u00a0\u00b1\u00a02.59  | 1.54\u00a0\u00b1\u00a02.72 |\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"5-Fu\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC<sub>50</sub>\",\n                \"value\": \"10.73 \u00b1 2.21\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"24h incubation, MCF-7 cell line\",\n            },\n            {\n                \"property name\": \"IC<sub>50</sub>\",\n                \"value\": \"1.54 \u00b1 0.77\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"48h incubation, MCF-7 cell line\",\n            },\n            {\n                \"property name\": \"IC<sub>50</sub>\",\n                \"value\": \"0.38 \u00b1 2.45\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"72h incubation, MCF-7 cell line\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"5-Fu.cp.1\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC<sub>50</sub>\",\n                \"value\": \"0.40 \u00b1 1.72\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"24h incubation, MCF-7 cell line\",\n            },\n            {\n                \"property name\": \"IC<sub>50</sub>\",\n                \"value\": \"0.39 \u00b1 1.23\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"48h incubation, MCF-7 cell line\",\n            },\n            {\n                \"property name\": \"IC<sub>50</sub>\",\n                \"value\": \"0.96 \u00b1 1.53\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"72h incubation, MCF-7 cell line\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 6, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Schematic Illustration<xref ref-type=\"fn\" rid=\"s1fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr1\" position=\"float\" xlink:href=\"am-2018-031116_0011.tif\"></graphic>\n<p>\n<fn id=\"s1fn1\">\n<label>a</label>\n<p>Schematic illustration of (a) hydrothermal synthesis of <bold>cp.1</bold> using Zn<sup>2+</sup>, K<sup>+</sup>, and 1,3,5-BTC; (b) 5-Fu loading\nprocess; and (c) drug release from 5-Fu-loaded <bold>cp.1</bold> during\n72 h, which was associated with collapse of crystalline structure\nof the synthesized <bold>cp.1</bold>.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 1  Schematic Illustration      a Schematic illustration of (a) hydrothermal synthesis of cp.1 using Zn2+, K+, and 1,3,5-BTC; (b) 5-Fu loading process; and (c) drug release from 5-Fu-loaded cp.1 during 72 h, which was associated with collapse of crystalline structure of the synthesized cp.1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Oak Ridge thermal\nellipsoid plot view of [Zn\u00ad(H<sub>2</sub>O)<sub>6</sub>K<sub>2</sub>(H<sub>2</sub>BTC)<sub>2</sub>(H<sub>2</sub>O)<sub>4</sub>]\u00ad(H<sub>2</sub>BTC)<sub>2</sub>\u00b72H<sub>2</sub>O, <bold>cp.1</bold>,\nwith the labeled atom scheme and displacement of ellipsoids.</p>\n</caption>\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"am-2018-031116_0013.tif\"></graphic>\n</fig>", "clean_text": " 1  Oak Ridge thermal ellipsoid plot view of [Zn(H2O)6K2(H2BTC)2(H2O)4](H2BTC)2\u22c52H2O, cp.1, with the labeled atom scheme and displacement of ellipsoids.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 25, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>View of the packing diagram of <bold>cp.1</bold> along <italic>a</italic> axis (a) and <italic>c</italic> axis (b).</p>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"am-2018-031116_0001.tif\"></graphic>\n</fig>", "clean_text": " 2  View of the packing diagram of cp.1 along a axis (a) and c axis (b).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 30, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>FE-SEM images of hydrothermally\nsynthesized <bold>cp.1</bold> before (a, b) and after (c, d) sieving.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"am-2018-031116_0002.tif\"></graphic>\n</fig>", "clean_text": " 3  FE-SEM images of hydrothermally synthesized cp.1 before (a, b) and after (c, d) sieving.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 33, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>FT-IR\nspectra of <bold>cp.1</bold> (a, black), 5-Fu-loaded <bold>cp.1</bold> (b, red), and 5-Fu (c, blue).</p>\n</caption>\n<graphic id=\"gr5\" position=\"float\" xlink:href=\"am-2018-031116_0003.tif\"></graphic>\n</fig>", "clean_text": " 4  FT-IR spectra of cp.1 (a, black), 5-Fu-loaded cp.1 (b, red), and 5-Fu (c, blue).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 36, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig5\" position=\"float\">\n<label>5</label>\n<caption>\n<p>PXRD patterns of simulated <bold>cp.1</bold> (a, green), synthesized <bold>cp.1</bold> (b, black),\n5-Fu-loaded <bold>cp.1</bold> (c, red), and 5-Fu (d, blue).</p>\n</caption>\n<graphic id=\"gr6\" position=\"float\" xlink:href=\"am-2018-031116_0004.tif\"></graphic>\n</fig>", "clean_text": " 5  PXRD patterns of simulated cp.1 (a, green), synthesized cp.1 (b, black), 5-Fu-loaded cp.1 (c, red), and 5-Fu (d, blue).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 39, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig6\" position=\"float\">\n<label>6</label>\n<caption>\n<p>5-Fu release\nfrom <bold>cp.1</bold> in 10% FBS at 37 \u00b0C.</p>\n</caption>\n<graphic id=\"gr7\" position=\"float\" xlink:href=\"am-2018-031116_0005.tif\"></graphic>\n</fig>", "clean_text": " 6  5-Fu release from cp.1 in 10% FBS at 37 \u00b0C.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 40, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig7\" position=\"float\">\n<label>7</label>\n<caption>\n<p>Powder XRD patterns of FBS (a) and 5-Fu-loaded <bold>cp.1</bold> after\n72 h release process in 10% FBS at 37 \u00b0C (b).</p>\n</caption>\n<graphic id=\"gr8\" position=\"float\" xlink:href=\"am-2018-031116_0006.tif\"></graphic>\n</fig>", "clean_text": " 7  Powder XRD patterns of FBS (a) and 5-Fu-loaded cp.1 after 72 h release process in 10% FBS at 37 \u00b0C (b).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 42, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig8\" position=\"float\">\n<label>8</label>\n<caption>\n<p>MTT assays of 5-Fu, 5-Fu-loaded <bold>cp.1</bold> as 5-Fu.<bold>cp.1</bold>, and <bold>cp.1</bold> in 24,\n48, and 72 h at the concentration range of 0 as control to 100 \u03bcg/mL\nagainst MCF-7 cells (a) and 4T1 cells (b). \u2605 indicates <italic>P</italic> &lt; 0.001 for 5-Fu vs 5-Fu.<bold>cp.1</bold> at the same\nconcentrations and same incubation times. Cell viability (%) comparison\nof 5-Fu.<bold>cp.1</bold> at different incubation times on MCF-7 cells\n(c) and 4T1 cells (d). The images of MCF-7 and 4T1 cells before and\nafter treatment with 5-Fu.<bold>cp.1</bold> (e) (asterisks show the\nstatistical significance).</p>\n</caption>\n<graphic id=\"gr9\" position=\"float\" xlink:href=\"am-2018-031116_0007.tif\"></graphic>\n</fig>", "clean_text": " 8  MTT assays of 5-Fu, 5-Fu-loaded cp.1 as 5-Fu.cp.1, and cp.1 in 24, 48, and 72 h at the concentration range of 0 as control to 100 \u03bcg/mL against MCF-7 cells (a) and 4T1 cells (b). \u2605 indicates P < 0.001 for 5-Fu vs 5-Fu.cp.1 at the same concentrations and same incubation times. Cell viability (%) comparison of 5-Fu.cp.1 at different incubation times on MCF-7 cells (c) and 4T1 cells (d). The images of MCF-7 and 4T1 cells before and after treatment with 5-Fu.cp.1 (e) (asterisks show the statistical significance).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 47, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig9\" position=\"float\">\n<label>9</label>\n<caption>\n<p>Confocal images of MCF-7 cells after being incubated with <bold>cp.1</bold> as blank (a), FITC-loaded <bold>cp.1</bold> (b), and\nLysoTracker Red for lysosome detection (c). From the left side, BF\nis the bright-field images of the cells. Green, red, and blue panels\nare dedicated to the fluorescent images, which are filtered by the\ngreen, red, and blue filters in CLSM. Merge is the overlays of fluorescent\nimages in each incubations. Scale bars: 100 \u03bcm.</p>\n</caption>\n<graphic id=\"gr10\" position=\"float\" xlink:href=\"am-2018-031116_0008.tif\"></graphic>\n</fig>", "clean_text": " 9  Confocal images of MCF-7 cells after being incubated with cp.1 as blank (a), FITC-loaded cp.1 (b), and LysoTracker Red for lysosome detection (c). From the left side, BF is the bright-field images of the cells. Green, red, and blue panels are dedicated to the fluorescent images, which are filtered by the green, red, and blue filters in CLSM. Merge is the overlays of fluorescent images in each incubations. Scale bars: 100 \u03bcm.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 49, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig10\" position=\"float\">\n<label>10</label>\n<caption>\n<p>(a) Effect of intratumoral\napplication of 5-Fu-loaded <bold>cp.1</bold> (red) and 5-Fu (blue)\non the growth of mammary adenocarcinoma 4T1 transplanted subcutaneously\ninto BALB/c mouse mammary glands. 5-Fu-loaded <bold>cp.1</bold> and\n5-Fu were injected with a dose of 11 mg/kg once on day 0 (10 days\nafter tumor transplantation). \u2033Black diamond minus white X\u2033\nindicates <italic>P</italic> &lt; 0.05 significant differences between\neach treatment and control. \u2033Double black diamond minus white\nX\u2033 indicates <italic>P</italic> &lt; 0.05 significant differences\nbetween 5-Fu-loaded <bold>cp.1</bold> and 5-Fu treatments on a particular\nday. Each experimental group consisted of five animals. (b) Photographs\nof stripped tumor tissues and (c) female BALB/c mice bearing breast\ncancer.</p>\n</caption>\n<graphic id=\"gr11\" position=\"float\" xlink:href=\"am-2018-031116_0009.tif\"></graphic>\n</fig>", "clean_text": " 10  (a) Effect of intratumoral application of 5-Fu-loaded cp.1 (red) and 5-Fu (blue) on the growth of mammary adenocarcinoma 4T1 transplanted subcutaneously into BALB/c mouse mammary glands. 5-Fu-loaded cp.1 and 5-Fu were injected with a dose of 11 mg/kg once on day 0 (10 days after tumor transplantation). \"Black diamond minus white X\" indicates P < 0.05 significant differences between each treatment and control. \"Double black diamond minus white X\" indicates P < 0.05 significant differences between 5-Fu-loaded cp.1 and 5-Fu treatments on a particular day. Each experimental group consisted of five animals. (b) Photographs of stripped tumor tissues and (c) female BALB/c mice bearing breast cancer.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 51, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig11\" position=\"float\">\n<label>11</label>\n<caption>\n<p>Histopathology of breast\ncancer in different groups. Thick arrows: mitotic figures; asterisks\n(*): necrosis area; thin arrows: infiltration of inflammatory cells.\nH&amp;E stain.</p>\n</caption>\n<graphic id=\"gr12\" position=\"float\" xlink:href=\"am-2018-031116_0010.tif\"></graphic>\n</fig>", "clean_text": " 11  Histopathology of breast cancer in different groups. Thick arrows: mitotic figures; asterisks (*): necrosis area; thin arrows: infiltration of inflammatory cells. H&E stain.   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/acsami.8b03111", "title": "\nDesign\nand Synthesis of a Biocompatible 1D Coordination Polymer as Anti-Breast\nCancer Drug Carrier, 5\u2011Fu: In Vitro and in Vivo Studies\n", "journal": "American\nChemical Society", "date": "2018.05", "author_list": ["Rezaei\nMahsa", "Abbasi\nAlireza", "Dinarvand\nRassoul", "Jeddi-Tehrani\nMahmood", "Janczak\nJan"]}}